Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010380	li-borrabg	— (—)	4483	4799	100.00%	Distribution not available
3010380	li-borrabg	au/ml (au/ml)	31	38	0.00%
3010380	li-borabgv	— (—)	27	29	100.00%	Distribution not available
3010380	li-borabgv	au/ml (au/ml)	16	16	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other symptoms and signs involving the nervous and musculoskeletal systems

807

1476

5.65

307.65

1.1

73.94

70.73

au/ml

—

Polyneuropathies and other disorders of the peripheral nervous system

465

609

7.99

307.65

1.1

94.07

38.77

au/ml

—

Symptoms and signs involving the nervous and musculoskeletal systems

1113

2021

5.68

307.65

1.1

59.65

71.49

au/ml

0.19

Headache

1053

1945

4.62

307.65

1.1

67.94

92.39

au/ml

0.37

Neurological diseases

1362

906

7.71

307.65

1.1

1.0

52.31

62.95

au/ml

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1341

2672

3.58

307.65

1.1

46.96

72.03

au/ml

—

Other and unspecified polyneuropathies, also in other diseases

394

514

8.02

284.47

1.1

94.07

38.77

au/ml

—

General symptoms and signs

1386

2173

3.24

280.74

1.1

45.46

79.52

au/ml

0.76

Spirochaetal infections, other/unspecified

279

255

11.91

265.92

1.2

1.1

88.89

—

au/ml

—

Other neurological diseases

910

2064

3.61

253.83

1.1

42.88

71.28

au/ml

—

Intracranial trauma

505

697

5.47

230.61

1.1

1.0

14.80

67.76

au/ml

—

Symptoms and signs involving the skin and subcutaneous tissue

890

2778

3.24

222.97

1.1

78.37

66.39

au/ml

—

Autoimmune diseases related-to ILD

1063

3251

2.92

215.88

1.1

41.22

71.04

au/ml

—

Autoimmune diseases excluding thyroid diseases

1262

2574

2.75

203.08

1.1

41.21

67.05

au/ml

0.65

Autoimmune diseases excluding thyroid diseases, strict definition

1233

2502

2.78

201.97

1.1

41.21

67.89

au/ml

0.66

Malaise and fatigue

568

1160

4.15

194.91

1.1

23.28

79.49

au/ml

—

Episodal and paroxysmal disorders

1255

2494

2.60

177.86

1.1

43.99

64.92

au/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

945

2430

2.86

176.79

1.1

63.83

67.17

au/ml

—

Dizziness and giddiness

784

2119

3.04

168.41

1.1

55.70

72.15

au/ml

—

ILD medications

1260

2900

2.41

155.92

1.1

46.61

73.70

au/ml

—

ILD medications: immunosuppressive drugs

737

2443

2.93

154.75

1.1

34.04

78.80

au/ml

—

Migraine

637

1724

3.19

149.97

1.1

—

71.62

—

Used for control exclusion in common control thyroid runs

1138

2391

2.43

140.82

1.1

48.63

66.97

au/ml

—

Fever of other and unknown origin

553

1595

3.25

137.97

1.1

67.94

83.29

au/ml

—

Autoimmune diseases

1179

2589

2.35

135.21

1.1

44.37

67.05

au/ml

—

Meningitis

160

176

9.82

133.57

1.3

1.0

72.50

—

au/ml

—

Other soft tissue disorders, not elsewhere classified

1013

2611

2.42

131.29

1.1

51.88

58.47

au/ml

—

Implicit Sepsis

751

2171

2.72

130.71

1.1

61.60

68.89

au/ml

—

Medical observation and evaluation for suspected diseases and conditions

731

1335

2.83

121.09

1.1

87.91

63.22

au/ml

—

Subjective visual disturbances

333

832

4.10

118.40

1.1

—

77.70

—

Nerve, nerve root and plexus disorders

1065

3001

2.25

117.89

1.1

62.94

65.32

au/ml

0.04

Motor neuron disease (with DMD)

64.99

117.26

1.0

—

Motor neuron disease

64.18

115.16

1.0

—

Cerebrovascular diseases

685

1845

2.69

114.39

1.1

86.66

65.74

au/ml

—

Guillain-Barre syndrome

20.34

108.93

1.2

1.1

—

Dorsalgia

1027

2507

2.24

107.94

1.1

63.87

86.79

au/ml

0.39

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

606

2127

2.67

106.29

1.1

53.46

73.50

au/ml

—

ILD medications: prednisolone, methylprednisolone, prednisone

1074

2832

2.16

105.09

1.1

46.61

73.70

au/ml

—

Certain infectious and parasitic diseases

990

2220

2.25

103.21

1.1

70.30

16.65

au/ml

—

Other dorsopathies, not elsewhere classified

1039

2525

2.19

102.95

1.1

54.48

86.79

au/ml

0.61

Other disorders of optic [2nd] nerve and visual pathways

152

216

7.44

102.33

1.1

—

Cerebral cysts

141

184

8.11

102.29

1.1

1.0

—

Benign intracranial hypertension

29.27

101.82

1.1

—

STROKE

608

1593

2.68

99.96

1.1

91.88

69.19

au/ml

—

Pain in limb

788

2459

2.34

99.00

1.1

70.94

58.47

au/ml

—

Use of teriflunomide

24.65

98.29

1.0

1.1

—

Other antidepressants

1022

2488

2.16

97.88

1.1

52.00

62.85

au/ml

—

Papilloedema, unspecified

13.47

95.82

1.1

—

Pain in joint

567

1411

2.69

92.73

1.1

46.46

58.63

au/ml

—

General examination and investigation of persons without complaint and reported diagnosis

639

1335

2.57

89.96

1.1

34.56

63.22

au/ml

—

Low back pain

710

2379

2.32

88.90

1.1

75.04

86.79

au/ml

—

Psychiatric diseases

1027

2491

2.08

88.55

1.1

68.20

66.58

au/ml

—

Stroke, excluding SAH

506

1395

2.72

87.66

1.1

67.60

74.42

au/ml

—

Diseases of the eye and adnexa

872

1989

2.21

87.57

1.1

40.63

71.53

au/ml

—

Stroke, including SAH

533

1526

2.61

85.05

1.1

81.43

72.02

au/ml

—

Ischaemic Stroke, excluding all haemorrhages

459

1284

2.73

80.35

1.1

67.60

77.99

au/ml

—

First line medication for Crohn's disease

1066

2999

1.95

79.45

1.1

46.61

76.07

au/ml

—

Examination and observation for other reasons

549

1322

2.55

79.18

1.1

62.80

63.22

au/ml

—

Migraine with aura

294

887

3.37

79.12

1.1

—

45.75

—

Pain (limb, back, neck, head abdominally)

684

1468

2.35

78.92

1.1

62.61

53.85

au/ml

—

Abnormal involuntary movements

174

362

4.93

78.37

1.1

—

41.28

—

Dorsopathies

989

2544

2.00

77.25

1.1

48.36

86.79

au/ml

0.90

Lower back pain or/and sciatica

953

3393

1.96

76.36

1.1

69.94

66.30

au/ml

0.05

Oral corticosteroids

986

3088

1.95

74.72

1.1

50.47

74.56

au/ml

—

Other special examinations and investigations of persons without complaint or reported diagnosis

622

1335

2.38

73.63

1.1

72.69

63.22

au/ml

—

Soft tissue disorders

994

2662

1.95

73.28

1.1

52.14

58.47

au/ml

—

Second line medication for Crohn's disease

563

2473

2.30

73.01

1.1

45.40

68.37

au/ml

—

Inflammatory bowel disease treatment related agents

1065

3242

1.88

71.73

1.1

46.61

74.56

au/ml

—

L04AX Other immunosuppressants

547

2400

2.30

71.15

1.1

45.40

68.37

au/ml

—

Opioids

958

2599

1.95

70.43

1.1

38.49

67.44

au/ml

—

Systemic atrophies primarily affecting the central nervous system

117

8.41

69.65

1.0

1.1

—

Migraine without aura

250

758

3.36

66.89

1.1

—

53.33

—

Small fibre neuropathy

10.74

62.66

1.1

—

Depression medications

367

652

2.86

61.89

1.1

1.0

—

62.30

—

Codeine

877

2548

1.90

61.14

1.1

67.29

67.44

au/ml

—

Alzheimer’s disease (Early onset), excluding more controls

21.10

61.10

1.0

—

Persons encountering health services for examination and investigation

585

1335

2.21

59.06

1.1

41.96

63.22

au/ml

—

Extrapyramidal and movement disorders

314

1171

2.71

58.14

1.1

71.32

73.24

au/ml

—

Care involving use of rehabilitation procedures

558

2567

2.08

56.10

1.1

—

72.72

—

Any gastric operation

770

2004

1.94

55.47

1.1

80.56

63.77

au/ml

—

GASTRO-related operations

770

2004

1.94

55.47

1.1

80.56

63.77

au/ml

—

Tramadol

679

2221

1.98

55.05

1.1

63.20

69.68

au/ml

—

Other intervertebral disc disorders

693

2165

1.97

55.05

1.1

22.00

86.79

au/ml

—

Sciatica+with lumbago

433

1824

2.27

54.44

1.1

71.67

99.26

au/ml

—

Other acute disseminated demyelination

14.98

53.81

1.1

—

Use of peginterferon beta-1a

41.08

53.38

1.1

1.3

—

Symptoms and signs involving the circulatory and respiratory systems

943

2672

1.78

52.16

1.1

33.24

64.61

au/ml

—

Other anxiety disorders

472

1973

2.14

50.54

1.1

—

60.01

—

Other extrapyramidal and movement disorders in other diseases

212

705

3.05

48.73

1.1

83.38

73.95

au/ml

—

Bacterial infection, other or unspecified

407

1670

2.22

47.78

1.1

43.80

73.81

au/ml

—

Diseases of the musculoskeletal system and connective tissue

530

1275

2.10

47.32

1.1

49.88

127.66

au/ml

—

Codeine or tramadol medication

977

3202

1.70

47.28

1.1

67.29

65.84

au/ml

—

Pain in throat and chest

733

2471

1.82

46.19

1.1

27.24

64.61

au/ml

—

Systemic connective tissue disorders

305

1259

2.45

45.90

1.1

49.26

71.42

au/ml

—

Symptoms and signs involving the digestive system and abdomen

865

2484

1.75

45.75

1.1

90.11

62.59

au/ml

—

Other specific joint derangements/joint disorders

674

2518

1.81

42.05

1.1

64.71

82.59

au/ml

—

Cervicalgia

186

632

2.98

41.21

1.1

—

115.27

—

Hard cardiovascular diseases

580

1991

1.88

40.80

1.1

74.78

71.55

au/ml

—

Bacterial meningitis

113

6.39

40.70

1.2

1.0

72.50

—

au/ml

—

Spondylopathies

579

1894

1.87

39.37

1.1

35.45

86.79

au/ml

—

Parasetamol

723

2103

1.76

39.29

1.1

57.24

66.67

au/ml

—

Other lack of coordination

10.28

39.05

1.1

—

Somatoform disorder

177

612

2.94

38.13

1.1

—

89.29

—

Sleep disorders (combined)

786

3130

1.65

35.92

1.1

85.19

62.42

au/ml

—

Malignant neoplasm of brain

112

5.97

35.32

1.2

1.1

—

Disorders of vestibular function (Vertigo)

346

1671

2.07

35.05

1.1

42.34

76.51

au/ml

—

Other and unspecified degenerative diseases of nervous system

9.96

34.40

1.2

1.0

—

Migraine with aura and triptan purchases

182

676

2.74

34.36

1.1

—

60.63

—

Abdominal and pelvic pain

806

2483

1.64

33.63

1.1

92.10

62.59

au/ml

—

Migraine without aura and triptan purchases

192

741

2.63

33.60

1.1

—

60.63

—

Benzodiazepine use

789

3493

1.61

33.38

1.1

37.03

72.52

au/ml

—

Alzheimer’s disease (Early onset)

7.44

33.14

1.0

1.1

—

Other disorders of binocular movement

6.97

32.60

1.1

—

Third [oculomotor] nerve palsy

9.07

32.60

1.1

—

Diseases of inner ear

388

2001

1.91

31.23

1.1

42.34

74.23

au/ml

—

Other diseases of urinary system

806

2851

1.60

31.21

1.1

45.43

69.88

au/ml

—

Diseases of the ear and mastoid process

963

3177

1.54

31.12

1.1

41.53

75.64

au/ml

—

Intracranial injury

443

2360

1.82

30.80

1.1

14.80

71.36

au/ml

—

Paraplegia, diplegia of upper limbs

7.51

30.79

1.2

1.1

—

Neuromuscular dysfunction of bladder

100

280

3.64

30.62

1.0

1.1

—

46.88

—

Postviral fatigue syndrome

12.71

30.52

1.1

—

Metabolic disorders

706

2704

1.63

30.24

1.1

73.52

70.08

au/ml

—

Persons encountering health services in other circumstances, wide

941

3194

1.53

30.15

1.1

55.29

67.21

au/ml

—

Malignant neoplasm of eye, brain and central nervous system

144

4.74

28.42

1.2

1.1

—

Other joint disorders

761

2573

1.58

28.04

1.1

47.71

82.59

au/ml

—

Non-invasive ventilation

186

723

2.44

27.75

1.1

—

75.11

—

Nonorganic sleeping disorders, excluding more controls

166

666

2.52

26.86

1.1

—

59.27

—

Shoulder lesions

548

1999

1.69

26.80

1.1

61.00

62.74

au/ml

—

Monoplegia

8.32

26.69

1.2

1.1

—

Other bacterial diseases

670

2933

1.59

26.36

1.1

73.66

67.57

au/ml

—

Meningitis, viral

18.08

25.89

1.4

1.1

—

Triptan medication for migraine, single purchase ok

648

2774

1.59

25.60

1.1

73.50

76.56

au/ml

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

648

2774

1.59

25.60

1.1

73.50

76.56

au/ml

—

Exclusions for E4_PCOS_BROAD

169

700

2.45

25.56

1.2

1.1

85.40

64.33

au/ml

—

Gastrointestinal diseases

550

1646

1.68

25.49

1.1

57.00

75.06

au/ml

—

Personality disorders, excluding more controls

224

1046

2.16

25.49

1.1

—

76.36

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

839

3186

1.51

25.35

1.1

34.76

67.21

au/ml

—

Dyspnoea

637

3097

1.58

25.29

1.1

115.60

62.97

au/ml

—

Diseases of the respiratory system

526

1562

1.69

25.08

1.1

61.14

87.56

au/ml

—

Acute upper respiratory infections of multiple and unspecified sites

591

2766

1.61

25.03

1.1

44.64

76.45

au/ml

—

Other diseases of intestines

843

3281

1.50

24.95

1.1

79.05

58.14

au/ml

—

Fall on same level

913

3471

1.47

24.75

1.1

72.63

70.96

au/ml

—

Fasciculation

9.43

24.47

1.0

1.1

—

COPD/asthma related infections

814

2709

1.51

24.19

1.1

33.17

81.44

au/ml

—

COPD/asthma/ILD related infections

814

2709

1.51

24.19

1.1

33.17

81.44

au/ml

—

Use of glatiramer acetate

6.75

24.17

1.1

—

Disorders of eyelid, lacrimal system and orbit

595

2959

1.58

23.89

1.1

51.11

74.07

au/ml

—

Injuries to the head

828

3654

1.48

23.67

1.1

24.54

75.99

au/ml

—

Influenza and pneumonia

804

3564

1.49

23.61

1.1

51.66

70.57

au/ml

—

Any operation in hilmo

14.12

23.36

1.1

1.0

—

Finngen Rheumatological endpoints

779

2969

1.50

23.20

1.1

56.24

78.03

au/ml

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

665

2704

1.55

23.17

1.1

51.66

81.44

au/ml

—

665

2704

1.55

23.17

1.1

51.66

81.44

au/ml

—

Bronchitis

795

3533

1.48

22.77

1.1

44.64

69.92

au/ml

—

Diseases of oesophagus, stomach and duodenum

792

3249

1.49

22.75

1.1

51.22

68.19

au/ml

—

134

531

2.56

22.39

1.1

—

82.80

—

Use of dimethyl fumarate

9.72

22.39

1.0

1.1

—

Dermatitis

433

2614

1.67

22.11

1.1

62.26

65.37

au/ml

—

Visual impairment including blindness (binocular or monocular)

176

3.82

21.81

1.2

1.1

—

Vocal cord dysfunction

115

394

2.74

21.79

1.2

1.1

—

80.21

—

Acute upper respiratory infections

765

3248

1.48

21.74

1.1

47.04

77.73

au/ml

0.90

Substance abuse, excluding more controls

376

1924

1.72

21.22

1.1

—

57.16

—

Sleep apnoea

642

2873

1.52

21.12

1.1

76.22

65.90

au/ml

—

Polyuria

160

708

2.28

20.90

1.1

—

57.28

—

SLE (Finngen)

5.19

20.80

1.1

—

Disorders of optic nerve, not elsewhere classified

6.29

20.47

1.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

162

729

2.24

20.34

1.1

—

74.84

—

Dermatitis and eczema

805

3673

1.44

20.17

1.1

67.91

67.09

au/ml

—

Asthma, unspecified (mode), excluding more controls

356

1627

1.73

20.09

1.1

—

82.20

—

832

3059

1.44

19.95

1.1

34.02

77.38

au/ml

2.09

Asthma, unspecified (mode)

358

1659

1.72

19.92

1.1

—

82.20

—

Other and unspecified dermatitis

362

2150

1.69

19.77

1.1

62.26

63.45

au/ml

—

Retrobulbar neuritis in diseases classified elsewhere

15.86

19.74

1.0

1.2

—

Arthropathies

744

2582

1.47

19.73

1.1

52.49

82.59

au/ml

—

Use of rivastigmine

247

3.18

19.68

1.1

—

57.50

—

Primary_lymphoid and hematopoietic malignant neoplasms

162

739

2.21

19.66

1.1

—

43.11

—

Pneumonia, organism unspecified

639

3102

1.50

19.63

1.1

58.43

65.45

au/ml

—

Temporal arteritis

5.07

19.33

1.1

—

Giant cell arteritis with polymyalgia rheumatica

5.01

19.07

1.1

—

Giant cell arteritis

4.70

18.99

1.1

—

Other diseases of upper respiratory tract

805

2938

1.43

18.75

1.1

38.15

79.91

au/ml

1.18

Secondary parkinsonism, excluding more controls

12.09

18.73

1.2

1.1

—

Myasthenia gravis

6.53

18.18

1.2

1.1

—

Generalized anxiety disorder

147

676

2.20

17.62

1.1

—

79.00

—

Sleep apnoea, including avohilmo

673

3021

1.45

17.49

1.1

72.54

69.81

au/ml

—

Falls/tendency to fall

852

3060

1.40

17.22

1.1

65.94

74.29

au/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

511

2111

1.53

17.02

1.1

58.53

71.27

au/ml

—

Disorders of other endocrine glands

312

1833

1.68

16.76

1.1

107.75

59.12

au/ml

—

Constipation

572

2783

1.48

16.63

1.1

103.88

65.01

au/ml

—

Behavioural syndromes associated with physiological disturbances and physical factors

264

1519

1.75

16.30

1.1

—

52.55

—

Pneumonias (Asthma/COPD co-morbidities)

713

3507

1.41

16.29

1.1

51.66

70.57

au/ml

—

Spinal stenosis

270

1211

1.75

16.29

1.1

41.94

86.54

au/ml

—

All pneumoniae

718

3523

1.41

16.27

1.1

51.66

70.57

au/ml

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

693

3447

1.42

16.15

1.1

51.66

70.57

au/ml

—

Chorioretinal inflammation

4.43

16.04

1.1

1.0

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

5.70

15.87

1.3

1.1

—

Voice disturbances

184

957

1.94

15.81

1.1

—

69.10

—

Other and unspecified paralytic syndromes

6.47

15.61

1.1

1.0

—

Brain glioblastoma and astrocytoma

5.60

15.58

1.3

1.1

—

Other and unspecified disorders of binocular movement

12.31

15.50

1.0

1.1

—

Sleep disorders

182

951

1.93

15.45

1.1

—

60.52

—

Nonorganic sleeping disorders

166

841

1.99

15.44

1.1

—

73.03

—

Immunodeficiency with predominantly antibody defects

4.64

15.28

1.2

1.1

—

Use of hypnotics and sedatives

759

3169

1.39

15.27

1.1

11.53

72.68

au/ml

—

Nystagmus and other irregular eye movements

6.18

14.92

1.1

—

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

396

2.45

14.89

1.1

—

25.86

—

Genitourinary diseases

484

1608

1.51

14.89

1.1

38.49

67.64

au/ml

—

Non-selective monoamine reuptake inhibitors

227

1248

1.77

14.75

1.1

—

65.58

—

Other disorders of peripheral nervous system

12.34

14.58

1.1

—

Other viral diseases, not elsewhere classified

158

808

1.97

14.23

1.1

—

58.66

—

Rheumatism, unspecified

100

429

2.35

14.23

1.1

—

86.30

—

Other symptoms and signs involving general sensations and perceptions

4.24

14.18

1.1

1.0

—

Optic atrophy

5.37

14.02

1.1

—

Disorders of speech understanding and production

157

3.32

13.95

1.1

—

Encephalopathy

7.53

13.69

1.1

1.0

—

Benign neoplasm of meninges

287

2.65

13.65

1.1

—

47.46

—

Injuries to the wrist and hand

701

3715

1.37

13.65

1.1

76.80

66.09

au/ml

—

Lung diseases due to external agents

360

2.44

13.43

1.2

1.1

—

25.41

—

Benign neoplasm: Cerebral meninges

254

2.71

13.00

1.1

—

47.46

—

Insomnia

137

698

1.98

12.65

1.1

—

90.29

—

Specific development disorders of speech and language

233

2.73

12.45

1.1

—

Diseases of the skin and subcutaneous tissue

750

2794

1.35

12.41

1.1

73.63

65.07

au/ml

0.12

Algoneurodystrophy

132

3.42

12.40

1.0

1.1

—

Hypothyroidism, drug reimbursement

109

359

2.18

12.27

1.2

1.0

—

70.09

—

Heartburn

322

2.45

12.17

1.0

1.1

—

71.83

—

Personality disorders

224

1343

1.68

12.09

1.1

—

79.18

—

Abnormal findings on diagnostic imaging of other body structures

391

2.30

12.07

1.1

—

72.23

—

Other disorders of optic disc

5.34

11.86

1.1

—

Diabetes insipidus

6.39

11.80

1.1

1.0

—

Disorders of the thyroid gland

652

3149

1.36

11.77

1.1

73.80

64.29

au/ml

—

Brain glioblastoma

5.74

11.76

1.4

1.1

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

5.60

11.46

1.4

1.1

—

Renal tubulo-interstitial diseases

556

3100

1.38

11.42

1.1

108.08

63.22

au/ml

—

Urticaria and erythema

263

1671

1.58

11.25

1.1

—

68.84

—

Other disorders of ear

581

2834

1.37

11.20

1.1

58.40

75.52

au/ml

—

All influenza (not pneumonia)

113

564

2.02

11.10

1.1

—

40.58

—

Other diseases of blood and blood-forming organs, wide

143

773

1.86

11.09

1.1

—

79.43

—

Dementia in other diseases classified elsewhere

3.81

11.05

1.1

—

Use of fingolimod

6.22

10.97

1.0

1.2

—

Disorders of synovium and tendon

329

1983

1.50

10.92

1.1

86.48

67.97

au/ml

—

Tetraplegia

9.73

10.85

1.2

1.0

—

Abnormal findings on examination of blood, without diagnosis

264

1581

1.57

10.84

1.1

58.67

69.90

au/ml

—

Polyarthropathies

449

2111

1.42

10.80

1.1

99.83

82.59

au/ml

—

Autonomic disorders

4.52

10.79

1.1

—

Other disorders of skin and subcutaneous tissue

401

2564

1.44

10.76

1.1

28.32

68.96

au/ml

—

Acute bronchitis

252

1571

1.58

10.69

1.0

1.1

—

83.02

—

Non-follicular lymphoma, hilmo, excluding all cancers

263

2.50

10.65

1.1

—

29.07

—

Undetermined asthma, excluding more controls

369

2.24

10.53

1.1

—

79.91

—

Trochanteric bursitis

383

2.21

10.48

1.1

—

99.02

—

Speech and linguistic disorders

367

2.22

10.47

1.1

—

Obesity related asthma

217

1343

1.62

10.41

1.1

—

82.78

—

Abnormal findings in cerebrospinal fluid

8.81

10.40

1.2

—

Chronic diseases of tonsils and adenoids

567

2649

1.36

10.35

1.1

22.38

91.84

au/ml

—

Undetermined asthma

373

2.21

10.27

1.1

—

79.91

—

Carpal tunnel syndrome

348

2159

1.46

10.15

1.1

91.28

83.76

au/ml

—

Benign neoplasms

597

2519

1.34

10.00

1.1

30.98

55.80

au/ml

—

Injuries to the neck

170

999

1.71

9.99

1.1

—

66.57

—

Benign neoplasm of other and unspecified endocrine glands

424

2.12

9.98

1.0

1.1

—

43.21

—

Alcohol use disorder, Swedish definition

349

2239

1.45

9.94

1.1

—

60.50

—

Specific personality disorders

190

1153

1.66

9.90

1.1

—

65.80

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

191

2.71

9.83

1.1

—

Asthma, hospital admissions 3, pneumonia

204

1260

1.62

9.82

1.1

—

80.56

—

Asthma-related pneumonia or sepsis

204

1260

1.62

9.82

1.1

—

80.56

—

Injuries to the knee and lower leg

810

3621

1.28

9.74

1.1

78.22

65.62

au/ml

—

Mononeuritis multiplex

11.10

9.72

1.4

1.0

—

Persistent mood disorders

133

737

1.82

9.60

1.1

—

79.79

—

Substance abuse

376

2546

1.42

9.41

1.1

—

56.81

—

Asthma-related pneumonia

202

1259

1.61

9.40

1.1

—

80.56

—

Diffuse large B-cell lymphoma

119

3.16

9.37

1.1

—

Other and unspecified mononeuropathies, also in other diseases

3.69

9.31

1.1

—

Viral infections of central nervous system, not elsewhere classified/unspecified

5.49

9.24

1.2

1.1

—

Cytomegalovirus infection, IBD co-morbidity

3.98

9.20

1.1

1.0

—

Diseases of oral cavity, salivary glands and jaws

619

2406

1.32

9.18

1.1

57.58

67.15

au/ml

—

Neoplasms

607

2465

1.32

9.09

1.1

64.70

61.20

au/ml

—

Mental and behavioural disorders due to psychoactive substance use

385

2603

1.40

9.04

1.1

—

55.83

—

385

2472

1.40

8.96

1.1

—

55.98

—

Other diseases of hard tissues of teeth

431

2339

1.38

8.91

1.1

63.20

68.96

au/ml

—

Infections of the skin and subcutaneous tissue

378

2702

1.40

8.86

1.1

37.92

68.57

au/ml

—

Pain and other conditions associated with female genital organs and menstrual cycle

170

991

1.66

8.81

1.1

—

58.54

—

363

2377

1.41

8.75

1.1

—

54.21

—

Urticaria

215

1387

1.56

8.74

1.1

—

61.03

—

Bleeding

476

2567

1.35

8.73

1.1

55.88

72.82

au/ml

—

Benign neoplasms

696

3024

1.29

8.65

1.1

46.77

72.58

au/ml

—

Benign neoplasm of other and unspecified endocrine glands

450

2.00

8.56

1.0

1.1

—

63.81

—

Non-allergic asthma (mode), excluding more controls

111

600

1.84

8.46

1.1

—

93.35

—

Cytomegaloviral disease

3.70

8.34

1.1

1.0

—

Non-allergic asthma (mode)

111

603

1.83

8.33

1.1

—

93.35

—

Dislocation, sprain and strain of joints and ligaments at neck level

125

712

1.77

8.32

1.1

—

63.57

—

Use of riluzole

9.79

8.20

1.0

1.1

—

Circumscribed brain atrophy

4.45

8.19

1.1

1.0

—

Cauda equina syndrome

4.68

8.19

1.1

—

Narcolepsy and cataplexy

6.78

8.14

1.1

1.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

276

1905

1.45

8.07

1.1

—

67.54

—

Disorders of choroid and retina

448

2429

1.35

8.04

1.1

55.88

70.99

au/ml

—

Injuries to the shoulder and upper arm

502

3198

1.32

8.00

1.1

44.63

70.46

au/ml

—

Diffuse brain injury

5.20

7.93

1.1

1.0

—

Nonpyogenic thrombosis of intracranial venous system

6.05

7.92

1.2

1.1

—

Complications of genitourinary prosthetic devices, implants and grafts

3.64

7.89

1.0

1.1

—

Disorders of conjunctiva

544

3508

1.30

7.87

1.1

62.23

73.01

au/ml

—

Benign neoplasm: Brain, supratentorial

4.15

7.86

1.0

1.1

—

Injuries to the thorax

252

1726

1.46

7.73

1.1

—

70.93

—

Mental and behavioural disorders due to alcohol

318

2212

1.40

7.70

1.1

—

61.05

—

Other/unspecified cytomegaloviral diseases

3.81

7.69

1.1

1.0

—

Hypoglycaemia, other or unspecified

237

2.30

7.52

1.1

—

Conjunctivitis

501

3352

1.31

7.49

1.1

62.23

79.29

au/ml

—

Phobic anxiety disorders

103

575

1.80

7.37

1.1

—

72.73

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.65

7.33

1.4

1.1

—

Myositis

3.54

7.30

1.1

—

Dental pulpitis 4

739

3073

1.25

7.27

1.1

32.74

67.46

au/ml

—

Dental pulpitis 1

739

3075

1.25

7.24

1.1

32.74

67.46

au/ml

—

Aplastic and other anaemias

216

1378

1.49

7.23

1.1

—

69.94

—

Drug-induced systemic lupus erythematosus

7.16

7.21

1.2

1.1

—

Superficial injury of lower leg

162

1027

1.59

7.21

1.1

—

86.59

—

Vascular syndromes of brain in cerebrovascular disorders

3.09

7.18

1.1

—

Benign neoplasm: Brain, supratentorial

3.85

7.14

1.0

1.1

—

Early lumbar disc prolapse, operated

390

1.96

7.09

1.0

1.1

—

101.48

—

Diseases of pulp and periapical tissues, including avohilmo

736

3071

1.25

7.04

1.1

32.74

67.46

au/ml

—

Cerebral amyloid angiopathy

14.92

7.03

1.1

—

Fourth [trochlear] nerve palsy

3.51

6.88

1.1

—

Other and unspecified anaemias

195

1258

1.50

6.87

1.1

—

73.41

—

Other and unspecified spinal muscular atrophies

5.62

6.83

1.2

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

179

1176

1.53

6.82

1.1

29.40

66.78

au/ml

—

Secondary hypertension

220

2.27

6.78

1.1

—

88.98

—

Other cranial nerve disorders in other disorders

13.60

6.77

1.0

1.1

—

Alcohol use disorder, ICD-based

248

1741

1.43

6.76

1.1

—

70.57

—

Inflammatory disease of uterus

110

644

1.72

6.74

1.0

1.1

—

89.57

—

Thiamine deficiency

6.03

6.67

1.0

1.1

—

Other anaemias

196

1271

1.49

6.66

1.1

—

73.41

—

Dental pulpitis 2, only avohilmo

455

1775

1.31

6.63

1.1

65.33

70.66

au/ml

—

Other/unspecified disorders of vestibular function

100

2.94

6.60

1.1

—

Bruxism

3.41

6.60

1.2

1.1

—

Vertigo of central origin

4.25

6.59

1.1

—

Hereditary ataxia

4.44

6.54

1.0

1.1

—

Other specified disorders of muscle

3.25

6.45

1.1

—

Dental pulpitis 2

443

1732

1.31

6.40

1.1

70.51

68.33

au/ml

—

Disorders of pituitary gland, other and/or unspecified

6.95

6.37

1.0

—

Reimbursement for rheumatic diseases

341

2545

1.34

6.33

1.1

80.20

65.36

au/ml

—

Immunodeficiencies

179

2.38

6.33

1.2

1.1

—

Other symptoms and signs involving the urinary system

309

2.02

6.32

1.0

1.1

—

33.38

—

Causalgia

3.91

6.30

1.1

—

Malignant immunoproliferative diseases

5.17

6.28

1.2

1.1

—

Nonhereditary hypogammaglobulinemia

4.81

6.26

1.1

—

Conductive and sensorineural hearing loss

427

2275

1.30

6.18

1.1

67.57

72.31

au/ml

—

Obstructive hydrocephalus

3.84

6.13

1.0

1.1

—

Emotional disorders and disorders of social functioning with onset specific to childhood

230

2.17

6.09

1.0

—

Thyroiditis, ILD-related definition

398

1.87

6.06

1.2

1.1

—

102.17

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

208

2.23

6.04

1.1

—

31.92

—

Sensorineural hearing loss

392

2094

1.31

6.04

1.1

67.57

72.80

au/ml

—

Moderate visual impairment, binocular

3.38

6.02

1.1

—

Parkinson's disease, strict definition

322

1.97

6.00

1.1

—

31.92

—

Unspecified visual impairment (binocular)

4.09

5.93

1.0

1.1

—

Early onset COPD, excluding more controls

577

1.70

5.90

1.1

—

79.78

—

Behavioural disorders, excluding more controls

3.24

5.88

1.1

—

Other or unspecified paralytic strabismus

5.70

5.86

1.4

1.1

—

Alcohol abuse, main dg, excluding more controls

512

1.75

5.85

1.1

—

69.79

—

Other and unspecified urticaria

135

865

1.57

5.84

1.1

—

73.03

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.17

5.79

1.2

—

Chronic gastritis

132

845

1.57

5.72

1.1

—

82.08

—

Emotional disorders starting during childhood or adolescence

218

2.16

5.72

1.0

—

Mild or no visual impairment, binocular

6.19

5.69

1.2

1.1

—

Melanocytic naevi of trunk

443

1.80

5.69

1.1

—

69.11

—

Abnormal reflex

6.17

5.69

1.1

1.2

—

Non-Hodgkin lymphoma, all

2.86

5.69

1.1

—

Eosinophilic disease (BM)

4.14

5.66

1.2

1.0

—

Dental pulpitis 4, only avohilmo

734

3157

1.22

5.65

1.1

34.74

68.90

au/ml

—

Drug-induced cataract

3.16

5.65

1.1

—

Dental caries 1

482

1938

1.27

5.62

1.1

70.51

65.87

au/ml

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

260

1224

1.38

5.61

1.1

—

84.00

—

Dental caries 3

518

2103

1.26

5.58

1.1

64.08

62.92

au/ml

—

Dental caries, including avohilmo

481

1938

1.27

5.53

1.1

70.51

65.87

au/ml

—

Hyperhidrosis

3.09

5.51

1.0

1.1

—

Superficial injury of hip and thigh

440

1.78

5.50

1.0

1.1

—

21.14

—

Diseases of male genital organs

314

1182

1.35

5.48

1.1

44.17

50.45

au/ml

—

Parkinson's disease

363

1.86

5.40

1.1

—

31.92

—

Malignant immunoproliferative diseases

4.47

5.34

1.2

1.1

—

Anaemia in chronic diseases classified elsewhere

3.23

5.34

1.1

—

Unspecified/other endometriosis

445

1.77

5.34

1.0

1.1

—

64.88

—

Open wound of wrist and hand

269

1979

1.35

5.31

1.1

—

62.02

—

Dental pulpitis 1, only avohilmo

731

3166

1.21

5.28

1.1

34.74

68.90

au/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

114

721

1.59

5.26

1.1

—

57.66

—

Melanocytic naevi of trunk

455

1.75

5.23

1.1

—

47.86

—

Other obstetric conditions, not elsewhere classified

263

1257

1.36

5.23

1.1

—

75.04

—

Polyarteritis nodosa and related conditions

3.83

5.12

1.0

1.1

—

Other and unspecified mononeuropathies of upper limb

2.80

5.06

1.3

1.1

—

Other and unspecified hydrocephalus

3.34

5.06

1.2

1.1

—

Dental caries 3 and operation codes

567

2368

1.23

4.96

1.1

61.34

64.21

au/ml

—

Superficial injury of head

129

851

1.52

4.95

1.1

—

73.18

—

Fracture of rib(s), sternum and thoracic spine

146

989

1.48

4.94

1.1

—

76.77

—

Meralgia paraesthetica

2.69

4.93

1.1

—

Other congenital malformations of circulatory system

2.82

4.90

1.0

1.1

—

Sequelae of inflammatory diseases of the central nervous system

12.19

4.86

1.3

1.0

—

Disorders of brain, other and unspecified

4.40

4.86

1.0

—

Personal history of risk-factors, not elsewhere classified

3.87

4.84

1.1

—

Iridocyclitis in diseases classified elsewhere

3.13

4.82

1.2

1.1

—

Vascular dementia (subcortical)

3.82

4.82

1.1

—

Other and unspecified trigeminal disorders

3.47

4.78

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

454

1.70

4.72

1.1

—

63.81

—

Other abnormal immunological findings in serum

3.26

4.64

1.0

1.1

—

Dental caries 1, only avohilmo

485

2002

1.24

4.63

1.1

62.80

66.20

au/ml

—

Dental caries 1 and operation codes

531

2221

1.23

4.61

1.1

61.34

66.85

au/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

592

3335

1.21

4.58

1.1

59.44

66.85

au/ml

—

Septal defects

242

1.96

4.56

1.1

—

Other specified and unspecified strabismus

3.68

4.52

1.1

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.67

4.52

1.2

1.1

—

Behavioural disorders

2.73

4.44

1.1

—

Degeneration of the brain due to alcohol

3.05

4.42

1.1

1.0

—

2.59

4.41

1.0

1.1

—

Muscle wasting and atrophy, not elsewhere classified

7.77

4.40

1.0

1.1

—

Diseases of liver

179

1289

1.39

4.40

1.1

—

79.97

—

Disorders of vitreous body and globe

236

1732

1.33

4.36

1.1

8.14

82.10

au/ml

—

Cerebral arteritis

12.45

4.35

1.4

1.0

—

Substance use, excluding alcohol

129

878

1.48

4.33

1.1

—

73.03

—

Degeneration of nervous system due to alcohol

3.00

4.30

1.1

1.0

—

Dental caries 3, only avohilmo

516

2164

1.22

4.28

1.1

57.20

63.36

au/ml

—

Other disorders of binocular vision

3.48

4.21

1.1

—

Other superficial mycoses

2.79

4.21

1.1

—

Neuralgic amyotrophy

8.93

4.19

1.1

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

121

2.34

4.19

1.2

1.1

—

Protozoal diseases

2.70

4.18

1.0

1.1

—

Attention to artificial openings

2.50

4.14

1.0

1.1

—

Secondary parkinsonism+Parkinsonism in other disease

2.83

4.14

1.2

1.1

—

Disorders of magnesium metabolism

4.50

4.13

1.1

1.0

—

Manic episode

104

2.43

4.07

1.0

1.1

—

Disorders of vitreous body

228

1692

1.32

4.04

1.1

8.14

82.10

au/ml

—

Secondary parkinsonism

2.79

4.03

1.2

1.1

—

Hyperosmolality and hypernatraemia

4.00

1.2

1.0

—

Hypersomnia

3.08

3.99

1.2

1.1

—

Mouth breathing

228

1735

1.32

3.94

1.1

—

66.34

—

Conduct disorder

2.54

3.90

1.1

—

Excessive attrition of teeth

254

1054

1.31

3.89

1.1

52.30

65.68

au/ml

—

Amblyopia ex anopsia

132

2.22

3.87

1.0

1.1

—

Secondary uncertain malignant neoplasm

359

1.71

3.84

1.1

—

21.14

—

Eosinophilia

3.12

3.83

1.2

1.1

—

Somnolence

3.59

3.79

1.3

1.1

—

Maltreatment syndromes

230

1.89

3.74

1.2

1.1

—

Common variable immunodeficiency

4.14

3.74

1.2

1.1

—

Other or unspecified common variable immunodeficiency

7.05

3.74

1.0

1.2

—

Rheumatoid arthritis

163

1085

1.37

3.65

1.1

80.20

111.64

au/ml

—

Misadventures to patients during surgical and medical care

481

1.59

3.63

1.1

—

79.34

—

Hypertensive encephalopathy

8.15

3.60

1.4

1.0

—

Transplanted organ and tissue status

351

1.69

3.60

1.1

—

21.86

—

Dental operations

378

1573

1.24

3.58

1.1

55.72

61.89

au/ml

—

Purpura and other haemorrhagic conditions

452

1.60

3.57

1.0

1.1

—

41.28

—

Fall on and from stairs and steps

137

982

1.40

3.55

1.1

—

74.27

—

Use of amantadine

2.86

3.55

1.0

1.1

—

Amyloidosis

3.08

3.54

1.1

1.0

—

Other diseases of arteries and capillaries

278

1.77

3.54

1.1

—

21.14

—

Other dialysis

105

2.32

3.54

1.0

1.1

—

Behçet disease

10.48

3.54

1.0

1.3

—

Lack of expected normal physiological development

3.00

3.53

1.0

1.1

—

Severe visual impairment, binocular

10.29

3.52

1.0

—

Fracture of lumbar spine and pelvis

628

1.50

3.51

1.1

—

67.67

—

Tic and related disorders

3.60

3.50

1.1

—

Fentanyl

228

1.85

3.49

1.0

1.1

—

31.50

—

Convergence insufficiency and excess

2.94

3.49

1.4

1.1

—

Vitamin D deficiency

2.70

3.42

1.1

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

7.30

3.40

1.0

—

Other and unspecified disorders of autonomic nervous system

5.99

3.39

1.3

1.0

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.53

3.39

1.4

1.1

—

Disorders of other and unspecified cranial nerves

5.91

3.37

1.3

1.1

—

Previous suicide attempt

3.32

3.37

1.1

—

Haemorrhage, not elsewhere classified

2.73

3.33

1.1

—

Biological medicines for asthma

2.97

3.32

1.1

—

Osteoporosis with pathological fracture (FG)

141

2.07

3.32

1.1

—

67.90

—

Autoimmune thyroiditis

2.58

3.32

1.3

1.1

—

Chronic inflammatory disorders of orbit

9.04

3.31

1.0

—

Other and unspecified coagulation defects

176

1.95

3.29

1.0

1.1

—

GI-bleeding

137

996

1.38

3.29

1.1

—

69.27

—

Acute disseminated encephalitis/encephalomyelitis

6.96

3.27

1.0

—

Disorders in reading

2.71

3.25

1.0

1.1

—

Other diseases of the digestive system

137

999

1.37

3.23

1.1

—

71.38

—

Severe visual impairment, monocular

3.66

3.22

1.5

1.1

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

2.29

3.21

1.0

1.1

—

Other diseases of liver

643

1.47

3.19

1.1

—

66.57

—

Sleep disorders, other/unspecified

117

2.16

3.17

1.1

—

Appendicitis, broad definition

453

3496

1.19

3.14

1.1

29.86

76.36

au/ml

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.14

3.11

1.2

1.1

—

L04AD Calcineurin inhibitors

429

1.57

3.11

1.0

1.1

—

47.60

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

106

1163

0.71

3.09

1.0

1.1

—

57.79

—

Atypical virus infections of central nervous system

3.31

3.08

1.1

—

Viral conjunctivitis

2.41

3.08

1.0

1.1

—

Acute appendicitis

429

3410

1.19

3.06

1.1

29.86

73.02

au/ml

—

Congenital malformations of cardiac septa

260

1.72

3.04

1.1

—

Procreative management

214

1416

1.28

3.00

1.1

—

52.90

—

Haemorrhage from respiratory passages

149

1034

1.34

2.99

1.1

—

74.24

—

Disorders of synovium and tendon in diseases classified elsewhere

2.66

2.98

1.0

1.1

—

Recurring oral aphthae, including avohilmo

514

1.50

2.97

1.0

1.1

—

47.86

—

Brain astrocytoma

4.92

2.96

1.1

1.2

—

Other erythematous conditions

114

2.13

2.95

1.0

1.1

—

Other and unspecified epidermal thickening

2.30

2.95

1.1

—

Intentional self-harm by unspecified means

3.20

2.95

1.4

1.1

—

Other and unspecified erythematous conditions

101

2.20

2.94

1.0

1.1

—

Diseases of appendix

454

3516

1.18

2.93

1.1

29.86

73.31

au/ml

—

Lesion of radial nerve

108

2.15

2.91

1.2

1.1

—

Other epidermal thickening

135

2.02

2.91

1.0

1.1

—

Mental and behavioural disorders due to opioids

156

1.94

2.91

1.1

1.0

—

Dental caries 2

494

3320

1.17

2.91

1.1

28.18

71.06

au/ml

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

6.90

2.89

1.0

1.2

—

Sequelae of injuries of neck and trunk

102

2.18

2.88

1.0

1.1

—

Superficial injury of thorax

519

1.49

2.85

1.1

—

37.10

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

118

596

1.39

2.85

1.1

—

80.17

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

4.64

2.84

1.1

1.2

—

Chronic iridocyclitis

186

1.84

2.84

1.1

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

2.81

2.83

1.2

1.1

—

Infective dermatitis

376

1.58

2.82

1.0

1.1

—

31.12

—

Cardiac murmurs and other cardiac sounds

341

1.60

2.81

1.1

—

85.00

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

4.02

2.80

1.2

1.1

—

Budesonide

505

1.49

2.80

1.1

—

73.06

—

Chronic lymphocytic leukaemia

2.49

2.80

1.3

1.1

—

Rheumatoid arthritis, including avohilmo

187

1461

1.28

2.80

1.1

80.20

57.76

au/ml

—

Cerebral oedema

8.89

2.79

1.2

1.0

—

Hepatic failure, not elsewhere classified

110

2.11

2.79

1.3

1.1

—

Other disorders starting during childhood or adolecense, excluding more controls

166

1.87

2.79

1.1

1.0

—

Alcohol induced polyneuropathy

3.99

2.79

1.2

1.0

—

Other specified/unspecified necrotizing vasculopathies

2.90

2.77

1.2

1.0

—

Other and unspecified myoneural disorders

5.21

2.76

1.0

1.1

—

Amyloidosis, other/unspecified

2.90

2.76

1.1

1.0

—

Moderate visual impairment, monocular

5.20

2.76

1.4

1.1

—

Scleritis

2.76

2.74

1.0

1.1

—

Disorder of external ear, unspecified

2.16

2.72

1.1

—

Other specified and unspecified disorders of eye and adnexa

125

2.02

2.71

1.0

1.1

—

Other forms of systemic lupus erythematosus

3.20

2.67

1.3

1.0

—

Gonarthrosis [arthrosis of knee](FG)

391

1940

1.19

2.66

1.1

31.68

89.55

au/ml

—

Pneumocystosis

2.83

2.66

1.0

1.1

—

Spinal osteochondrosis

3.18

2.66

1.0

1.2

—

Injury of nerves at wrist and hand level

133

1.97

2.66

1.0

1.1

—

Crohn disease (strict definition, all UC cases excluded)

205

1.77

2.66

1.1

—

Epileptic seizures related to drugs

4.91

2.64

1.1

—

Disturbance of activity and attention

498

1.47

2.62

1.0

1.1

—

Other maltreatment syndromes

134

1.96

2.61

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

489

1.48

2.60

1.2

1.1

—

78.32

—

Diverticular disease of intestine

337

1870

1.20

2.59

1.1

110.15

62.12

au/ml

—

Injury of nerves at hip and thigh level

5.65

2.57

1.0

1.2

—

Colour vision deficiencies

5.61

2.56

1.0

—

Female infertility, cervigal, vaginal, other or unspecified origin

191

1008

1.27

2.56

1.1

—

71.29

—

Diseases of spleen

2.64

2.54

1.0

1.1

—

Ehlers-Danlos syndrome

3.09

2.54

1.1

—

Complications of other internal prosthetic devices, implants and grafts

101

2.10

2.53

1.2

1.1

—

Use of disulfiram, acamprosate or naltrexone

363

1.55

2.53

1.0

1.1

—

49.88

—

Endometriosis of pelvic peritoneum

105

759

1.37

2.51

1.0

1.1

—

58.54

—

Other diseases of blood and blood-forming organs

224

1.71

2.50

1.1

—

Drug-induced headache, not elsewhere classified

4.49

2.50

1.3

1.1

—

Generalized epilepsy

165

1.83

2.49

1.0

1.1

—

Congenital malformations of spine and bony thorax

3.91

2.49

1.3

1.1

—

Atrial septal defect

150

1.87

2.47

1.0

1.1

—

Dental caries 2, only avohilmo

482

3293

1.16

2.47

1.1

28.18

71.06

au/ml

—

Dental caries 2 and operation codes

481

3310

1.16

2.47

1.1

28.18

71.06

au/ml

—

Agoraphobia

123

1.97

2.46

1.1

1.0

—

Other and unspecified diseases of blood and blood-forming organs

2.31

2.42

1.0

1.1

—

Syndrome of inappropriate secretion of antidiuretic hormone

5.13

2.42

1.2

1.0

—

Other congenital malformations of respiratory system

6.69

2.42

1.2

1.0

—

Other and unspecified vaccines and biological substances

3.42

2.42

1.1

—

Epidural haemorrhage

5.06

2.41

1.2

1.0

—

Benign neoplasm: Brain, unspecified

3.73

2.39

1.1

1.2

—

Other or unspecified ileus, impaction or obstruction

540

1.43

2.38

1.0

1.1

—

53.80

—

Other sexually transmitted chlamydial diseases

338

1.55

2.35

1.1

—

Anomalies of pupillary function

2.33

2.32

1.0

1.1

—

Early lumbar disc prolapse operation

536

1.42

2.30

1.0

1.1

—

49.88

—

Alcohol abuse, main dg

645

1.38

2.30

1.1

—

67.96

—

Hypertrichosis

2.14

2.30

1.1

—

Secondary thrombocytopenia

2.73

2.29

1.0

1.1

—

Symptoms and signs involving emotional state

2.14

2.29

1.0

1.1

—

Chronic periodontitis

470

1.45

2.29

1.1

—

105.93

—

Injury of blood vessels at lower leg level

4.75

2.29

1.0

1.1

—

Complications following infusion, transfusion and therapeutic injection

2.72

2.29

1.0

1.1

—

Malnutrition

2.48

2.29

1.2

1.1

—

Synovial hypertrophy, not elsewhere classified

4.67

2.28

1.0

1.2

—

Explicit fungal Sepsis

3.98

2.27

1.0

1.2

—

Palmar fascial fibromatosis [Dupuytren]

389

1.50

2.27

1.1

—

91.27

—

Retinal detachment with retinal break

390

1.49

2.25

1.1

—

21.86

—

Malignant neoplasm of digestive organs

1100

0.72

2.25

1.1

—

73.93

—

Acute alcohol intoxication, ICD10

110

828

1.33

2.24

1.1

—

64.43

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

142

1.85

2.24

1.1

—

Sleepwalking [somnambulism]

5.78

2.24

1.0

—

Dialysis

142

1.85

2.24

1.1

1.0

—

Hereditary hypogammaglobulinemia

5.73

2.23

1.0

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.36

2.23

1.1

—

Habit and impulse disorders

2.36

2.23

1.1

—

Cholecystectomy

358

2708

1.17

2.23

1.1

54.17

78.78

au/ml

—

Other and unspecified neuropathies

5.70

2.23

1.0

1.1

—

Event of undetermined intent

240

1.63

2.22

1.1

1.0

—

Nonsuppurative otitis media

149

1009

1.28

2.22

1.0

1.1

—

39.88

—

Hirsutism in women

2.22

1.1

—

Lagophthalmos

2.82

2.21

1.2

1.1

—

Kyphosis

2.82

2.21

1.0

1.1

—

Other acute viral hepatitis

2.54

2.20

1.0

1.1

—

Benign neoplasm: Spinal cord

2.54

2.20

1.4

1.1

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.40

2.19

1.4

1.0

—

Marginal zone B-cell lymphoma

3.40

2.19

1.3

1.0

—

Viral and other specified intestinal infections

132

999

1.29

2.19

1.1

—

35.04

—

Other abnormal products of conception

215

1169

1.23

2.18

1.0

1.1

—

74.25

—

Toxoplasmosis

3.78

2.17

1.0

1.2

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

147

1218

0.79

2.16

1.1

—

76.38

—

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

147

1218

0.79

2.16

1.1

—

76.38

—

TMD muscular pain linked with fibromyalgia

3.06

2.16

1.0

1.1

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.74

2.16

1.0

1.1

—

Burns classified according to extent of body surface involved

3.05

2.16

1.1

—

Impetigo

174

1.74

2.14

1.1

—

Unspecified event, undetermined intent

2.12

2.13

1.0

1.1

—

Torticollis

2.39

2.13

1.2

—

Background retinopathy and retinal vascular changes

2.39

2.13

1.2

1.1

—

Horner syndrome

2.49

2.12

1.1

—

Benign neoplasm: Brain, unspecified

3.28

2.11

1.1

1.2

—

Nail dystrophy

3.28

2.11

1.0

1.1

—

Burns and corrosions confined to eye and internal organs

102

1.98

2.11

1.1

—

Hereditary motor and sensory neuropathy

3.26

2.11

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

463

1.43

2.09

1.0

1.1

—

25.86

—

Injury of nerves at lower leg level

2.95

2.08

1.0

1.1

—

Obesity, other/unspecified

189

1540

1.23

2.07

1.0

1.1

—

63.25

—

Other and unspecified disorders of adult personality and behaviour

3.58

2.07

1.0

1.2

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

207

0.43

2.07

1.0

1.1

—

27.84

—

Sequelae of other external causes

176

1.71

2.06

1.0

1.1

—

Extracorporeal dialysis

199

1.67

2.05

1.0

1.1

—

Benign neoplasm: Ascending colon

374

1.48

2.05

1.0

1.1

—

26.04

—

Benign neoplasm: Ascending colon

374

1.48

2.05

1.0

1.1

—

19.62

—

Gastroduodenal ulcer

726

1.34

2.05

1.1

—

70.28

—

Malignant neoplasm of breast

163

1461

0.80

2.04

1.1

—

93.29

—

Personal history of certain other diseases

2.13

2.03

1.3

1.1

—

Other embolism and thrombosis

400

1.45

2.02

1.0

1.1

—

63.63

—

Other specified/unspecified disorders of bone/cartilage

104

1.94

2.01

1.0

1.1

—

Hernia

523

3138

1.13

2.01

1.1

79.17

68.05

au/ml

—

COPD (mode)

113

688

1.31

1.99

1.1

—

77.57

—

Injury of eye and orbit

578

1.37

1.98

1.0

1.1

—

38.61

—

Other and unspecified injuries of head

186

1.68

1.97

1.1

—

Benign neoplasm: Spinal cord

2.39

1.96

1.4

1.1

—

Other and unspecified injuries of shoulder and upper arm

1.95

1.96

1.1

—

Implicit parasitic Sepsis

3.85

1.95

1.0

1.1

—

Disorders of male genital organs in diseases classified elsewhere

3.82

1.95

1.2

1.1

—

Hypertrophy of (infrapatellar) fat pad

3.00

1.94

1.1

—

Vascular dementia (multiple infarctions)

4.56

1.94

1.2

1.0

—

Disorder of thyroid, unspecified

2.76

1.94

1.1

1.2

—

Ulcerative ileocolitis

172

0.40

1.91

1.1

—

Benign neoplasm: Cranial nerves

2.02

1.91

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative

157

1426

0.81

1.90

1.1

—

93.29

—

Other and unspecified disorders of vitreous body

171

1386

1.23

1.90

1.1

8.14

77.63

au/ml

—

Peritonsillar abscess

120

939

1.28

1.90

1.1

—

83.71

—

Drug-induced tremor

3.25

1.89

1.0

1.2

—

Drug-induced osteoporosis

2.68

1.87

1.0

1.1

—

Other factor of the environment

2.68

1.87

1.0

1.1

—

Alcohol dependence

135

1074

1.26

1.87

1.1

—

72.77

—

Acute alcohol intoxication

127

1003

1.27

1.87

1.1

—

76.11

—

Colorectal adenocarcinoma

542

0.64

1.86

1.1

—

46.21

—

Kidney transplant status

205

1.62

1.86

1.1

—

Tic and related disorders

2.42

1.86

1.1

—

Lupus erythematosus

2.04

1.86

1.3

1.1

—

Oesophageal obstruction

1.95

1.85

1.1

—

Later onset COPD

521

0.68

1.85

1.1

—

58.00

—

Superficial frostbite

3.59

1.85

1.0

1.2

—

Other abnormalities of plasma proteins

2.53

1.84

1.0

1.1

—

Dementia due to Parkinson's disease

2.52

1.84

1.1

—

Listeriosis

4.27

1.83

1.2

1.0

—

Motor disorders, excluding more controls

2.41

1.83

1.0

1.1

—

Endometriosis ASRM stages 1,2

106

822

1.29

1.82

1.0

1.1

—

84.13

—

Salpingitis and oophoritis

691

1.32

1.82

1.1

—

88.43

—

Protein-energy malnutrition of moderate and mild degree

3.09

1.81

1.3

1.0

—

Drug-induced polyneuropathy

3.09

1.81

1.0

—

Pneumonia due to other infectious organisms, not elsewhere classified

1.93

1.80

1.1

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

2.81

1.80

1.1

—

Early onset COPD

753

1.30

1.80

1.1

—

84.33

—

Atherosclerosis, excluding cerebral and coronary sclerosis

977

0.77

1.79

1.0

1.1

—

63.09

—

Lateral epicondylitis

436

1.40

1.78

1.1

—

114.43

—

Late syphilis

2.47

1.76

1.4

1.0

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

446

1.39

1.75

1.1

—

43.34

—

Benign neoplasm: Cranial nerves

1.95

1.75

1.0

1.1

—

Muscle strain

1.94

1.75

1.0

1.1

—

Chronic myeloproliferative disease

2.53

1.75

1.1

—

Left ventricular outflow tract obstruction, narrow definition

191

0.47

1.73

1.1

—

Dermatitis due to substances taken internally

178

1.64

1.73

1.1

—

Pregnancy with abortive outcome

389

1782

1.14

1.72

1.1

—

80.93

—

Benign neoplasm: Prostate

3.91

1.72

1.2

—

Intercostal neuropathy

3.90

1.72

1.0

1.2

—

Benign neoplasm: Tonsil

0.00

1.71

0.0

1.1

—

Cardiac arrest

133

1.69

1.71

1.0

1.1

—

Acute generalized exanthematous pustulosis

148

1.70

1.1

—

Other abnormal findings of blood chemistry

133

1.74

1.70

1.0

1.1

—

Tic disorders

2.41

1.68

1.1

—

Asymptomatic human immunodeficiency virus [HIV] infection status

3.22

1.67

1.0

1.2

—

Muscular dystrophy

2.63

1.67

1.0

—

Polyarteritis nodosa

3.21

1.67

1.0

1.2

—

Injury of nerves at ankle and foot level

2.85

1.66

1.0

1.2

—

Benign neoplasm: Spinal meninges

2.84

1.66

1.6

1.0

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

511

1.35

1.65

1.1

—

56.49

—

Melanocytic naevi of upper limb, including shoulder

1.99

1.65

1.0

1.1

—

Melanocytic naevi of upper limb, including shoulder

1.99

1.65

1.0

1.1

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.27

1.64

1.2

1.1

—

Gastric ulcer

503

1.35

1.64

1.1

—

61.77

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

525

0.66

1.64

1.1

—

48.76

—

Malignant neoplasm of pancreas

147

0.41

1.64

1.0

1.1

—

Glaucoma

228

1702

1.18

1.63

1.1

108.74

64.33

au/ml

—

Other hypertrichosis

3.67

1.63

1.2

1.1

—

Oesophageal varices

130

0.38

1.63

1.0

1.1

—

Hypertrophic cardiomyopathy

132

0.38

1.62

1.0

1.1

—

Benign neoplasm: Prostate

3.63

1.62

1.2

1.1

—

Hyperkinetic disorders

549

1.34

1.62

1.0

—

Other disorders of thyroid

2.35

1.61

1.1

—

L02BA Anti-estrogens

582

0.69

1.61

1.2

1.1

—

104.81

—

Drug-induced hypoglycaemia without coma

2.35

1.61

1.1

—

Chronic hepatitis, not elsewhere classified

113

1.78

1.61

1.2

1.1

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

113

1.78

1.61

1.0

1.1

—

Acute mastoiditis

2.54

1.60

1.0

1.2

—

Deficiency of other B group vitamins

2.08

1.60

1.1

—

Retinal haemorrhage

2.08

1.60

1.1

—

Injuries to the elbow and forearm

374

2986

1.13

1.60

1.1

28.42

71.40

au/ml

—

Aspergillosis

3.04

1.59

1.0

1.1

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

251

1.50

1.59

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

527

3088

1.11

1.58

1.1

62.88

67.15

au/ml

—

Chronic viral hepatitis

231

1.52

1.57

1.1

—

Congenital malformations of aortic and mitral valves

157

0.44

1.55

1.1

—

Neovascular glaucoma

107

1.79

1.55

1.1

—

Other abortion

2.46

1.54

1.0

1.1

—

Viral pneumonia (known virus, not influenza)

2.05

1.54

1.0

1.1

—

Benign neoplasm: Descending colon

176

1.60

1.54

1.1

—

26.26

—

Psoas tendinitis

3.41

1.53

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

687

1.29

1.53

1.1

—

21.86

—

Benign neoplasm: Tonsil

0.00

1.53

0.0

1.1

—

Dental operations, only avohilmo

384

1738

1.13

1.53

1.1

51.27

72.02

au/ml

—

Preparatory care for dialysis

138

1.68

1.52

1.1

—

Increased muscle tone

2.90

1.51

1.2

1.1

—

Disorder of pancreatic internal secretion, other and/or unspecified

2.90

1.51

1.2

1.1

—

Abnormal findings in nipple discharge synovial fluid wound secretions

2.18

1.51

1.1

—

Glaucoma secondary to other eye disorders

108

1.77

1.51

1.1

—

Secondary polycythaemia

1.96

1.49

1.0

1.1

—

Injury of nerves at forearm level

2.46

1.48

1.0

1.1

—

Postzoster neuralgia

2.46

1.48

1.3

1.0

—

Acute myeloid leukaemia and myelodysplastic syndromes

2.45

1.48

1.0

1.1

—

Drug-induced osteoporosis with pathological fracture

2.25

1.47

1.2

1.0

—

Arthrosis

383

1867

1.13

1.47

1.1

37.52

104.45

au/ml

—

Disorders of gallbladder, biliary tract and pancreas

535

3119

1.11

1.47

1.1

46.03

74.22

au/ml

—

Diseases of arteries, arterioles and capillaries

287

1869

1.15

1.47

1.1

—

72.08

—

Phlebitis and thrombophlebitis (not including DVT)

101

804

1.26

1.46

1.1

—

79.01

—

Endometriosis diagnosis and infertility diagnosis occurring together

514

1.33

1.46

1.1

—

121.08

—

Burn and corrosion confined to eye and adnexa

1.85

1.46

1.1

—

Cholecystitis

402

1.37

1.46

1.1

—

30.27

—

Other and unspecified injuries of wrist and hand

132

1.68

1.46

1.0

1.1

—

Symptoms and signs involving appearance and behaviour

2.53

1.46

1.0

1.1

—

Wegener granulomatosis

2.14

1.45

1.0

1.1

—

Unspecified transport accident

3.19

1.45

1.0

1.2

—

Mature T/NK-cell lymphomas, hilmo

2.33

1.43

1.0

1.1

—

Testicular hypofunction

110

1.74

1.43

1.1

—

Colon adenocarcinoma

303

0.59

1.43

1.1

—

20.32

—

Other bursopathies

370

1.38

1.43

1.0

1.1

—

136.12

—

Anisometropia and aniseikonia

103

1.76

1.41

1.2

1.1

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

2.27

1.41

1.0

1.1

—

Xerosis cutis

2.27

1.40

1.0

1.1

—

Erosion of teeth

2.19

1.40

1.0

1.1

—

Other bacterial agents as the cause of diseases classified to other chapters

2.44

1.40

1.3

1.1

—

Haemolytic anaemias

111

1.72

1.39

1.1

—

Other renal tubulo-interstitial diseases

1.91

1.39

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

517

0.69

1.39

1.0

1.1

—

48.76

—

Acquired haemolytic anaemia

1.96

1.39

1.1

—

Infections of genitourinary tract in pregnancy

441

1.34

1.38

1.1

—

85.00

—

Benign neoplasm: Skin of lower limb, including hip

1.81

1.37

1.0

1.1

—

Atlantoaxial subluxation

2.65

1.37

1.0

—

Exposure to other and unspecified animate mechanical forces

112

1.71

1.36

1.0

1.1

—

Ulcerative colitis (strict) with PSC

0.00

1.35

0.0

1.1

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

1.35

0.0

1.1

—

Benign neoplasm: Short bones of lower limb

0.00

1.35

0.0

1.2

—

Dermatitis due to ingested food

153

1.58

1.34

1.2

1.1

—

Disorders of iron metabolism

2.16

1.34

1.1

—

Female infertility, associated with anovulation

401

1.35

1.33

1.1

—

55.73

—

Major coronary heart disease event excluding revascularizations

217

1731

0.86

1.33

1.1

60.87

80.76

au/ml

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

357

0.64

1.32

1.1

—

25.86

—

Peripheral artery disease

109

1074

0.82

1.32

1.1

—

66.01

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.82

1.32

1.2

1.0

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.00

1.31

0.0

1.1

—

Exposure to other specified electric current

2.11

1.31

1.0

1.1

—

Disorder of lipoprotein metabolism, unspecified

368

1.36

1.30

1.1

—

52.45

—

Vascular dementia (undefined)

2.41

1.30

1.3

1.0

—

Other abnormal auditory perceptions

2.38

1.30

1.0

1.1

—

Other papulosquamous disorders

2.38

1.30

1.1

—

Hydrocephalus in other diseases

2.82

1.29

1.0

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

2.82

1.29

1.0

—

Other disorders starting during childhood or adolescence

224

1.47

1.29

1.1

—

Calcific tendinitis

2.80

1.29

1.0

1.1

—

Malignant melanoma of skin

335

1.38

1.28

1.1

—

41.28

—

Benign neoplasm: Stomach

276

1.42

1.28

1.1

—

52.13

—

Sexual dysfunction

2.02

1.28

1.0

1.1

—

Other disorders involving the immune mechanism, not elsewhere classified

1.73

1.27

1.3

1.1

—

Other maternal disorders predominantly related to pregnancy

345

1935

1.12

1.27

1.1

127.20

65.54

au/ml

—

Specific developmental disorder of motor function

2.02

1.27

1.0

1.1

—

Bicuspidal aortic valve syndrome

135

0.44

1.27

1.2

1.1

—

2.31

1.27

1.3

1.1

—

Tularaemia

2.31

1.27

1.3

1.1

—

Generalized skin eruption due to drugs and medicaments

130

1.62

1.27

1.1

—

Erosion of teeth, including avohilmo

110

871

1.22

1.26

1.0

1.1

—

57.82

—

Injury of cranial nerves

2.44

1.25

1.0

—

Dissection of cerebral arteries, nonruptured

2.43

1.25

1.2

1.1

—

Acute myeloid leukaemia

2.42

1.25

1.0

1.1

—

DVT of lower extremities

581

1.28

1.24

1.1

—

79.01

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

2.24

1.24

1.0

1.1

—

Unspecified abortion

195

1.49

1.24

1.1

—

121.08

—

Hypertrophy of tongue papillae

2.02

1.24

1.0

1.1

—

Medicines for HER+ breast cancer

108

1276

0.82

1.23

1.2

1.1

—

89.97

—

Burn and corrosion of wrist and hand

147

1.57

1.23

1.0

1.1

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

290

0.62

1.23

1.1

—

26.04

—

Cholinergic urticaria

2.68

1.22

1.0

1.1

—

Marfan's syndrome

2.67

1.22

1.0

1.2

—

Maxillary prognathism

2.67

1.22

1.0

1.1

—

Multifocal fibrosclerosis

2.67

1.22

1.0

1.1

—

Intentional self-harm by hanging, strangulation and suffocation

2.67

1.22

1.2

—

Other specified and unspecified disorders of lens

2.66

1.22

1.0

1.2

—

Injury of nerves and spinal cord at neck level

1.84

1.20

1.1

—

COPD, hospital admissions 1, only main diagnosis

878

0.80

1.19

1.1

—

61.02

—

Other overlap syndromes

1.89

1.18

1.2

1.1

—

Specific development disorders of scholastic skills

187

1.49

1.18

1.0

1.1

—

Calcific aortic valvular stenosis, operated

712

0.77

1.18

1.1

—

56.28

—

Calcific aortic valvular stenosis

712

0.77

1.18

1.1

—

56.28

—

Testicular dysfunction

125

1.61

1.18

1.1

—

Arthropathic psoriasis

419

1.32

1.17

1.0

1.1

—

85.00

—

Other and unspecified mononeuropathies of lower limb

1.78

1.17

1.2

1.1

—

Von Willebrand disease

2.02

1.17

1.3

1.1

—

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

752

0.78

1.17

1.0

1.1

—

72.11

—

Benign neoplasm: Short bones of lower limb

0.00

1.16

0.0

1.2

—

Other chromosome abnormalities, not elsewhere classified

2.55

1.16

1.0

1.2

—

Operations 2 for CAVS

710

0.77

1.16

1.1

—

56.27

—

Calcific aortic valvular stenosis, diagnosis (helper)

710

0.77

1.16

1.1

—

56.27

—

Other misadventures during surgical and medical care

1.82

1.15

1.0

1.1

—

Blindness, monocular

2.52

1.15

1.2

1.1

—

Delayed puberty

2.52

1.15

1.4

1.1

—

Respiratory tuberculosis, not confirmed

1.73

1.15

1.0

1.1

—

Other arthrosis

241

1518

1.14

1.15

1.1

37.40

104.45

au/ml

—

Other and unspecified injuries of ankle and foot

158

1.53

1.15

1.2

1.1

—

Barrett oesophagus

142

1.56

1.14

1.1

—

Acne vulgaris

413

1.31

1.13

1.2

1.1

—

Other bullous disorders

1.76

1.13

1.1

—

Other specified disorders of external ear

111

0.45

1.13

1.0

1.1

—

Separation of retinal layers (serosa)

151

1.53

1.12

1.1

1.0

—

Motor disorders

1.91

1.11

1.0

1.1

—

Other disorders of Eustachian tube

1.71

1.11

1.1

—

Tuberculosis of other organs, strict

1.97

1.11

1.1

—

Peripheral arterial reconstruction

389

0.69

1.11

1.0

1.1

—

54.58

—

Lifestyle-related condition

2.28

1.11

1.0

1.1

—

Infections specific to the perinatal period

2.28

1.10

1.0

—

Other bursitis of knee

2.28

1.10

1.3

1.1

—

Other abnormal findings in urine

2.27

1.10

1.0

1.2

—

Lung transplant status

2.41

1.09

1.2

1.0

—

Lung transplantation

2.41

1.09

1.2

1.0

—

Neuroendocrine tumor and carcinoma of lung

2.41

1.09

1.0

—

Open wound of neck

2.40

1.09

1.0

1.2

—

Benign neoplasm: Duodenum

1.83

1.09

1.2

1.1

—

Occlusion and stenosis of arteries, not leading to stroke

2.39

1.09

1.4

1.0

—

Cellulitis of external ear

1.97

1.09

1.1

—

Haemorrhagic and haematological disorders of fetus and newborn

1.79

1.09

1.0

—

Mixed disorders of conduct and emotions, excluding more controls

1.74

1.09

1.1

—

Other other unspecified disorders of the circulatory system

112

1.62

1.09

1.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

112

1.62

1.09

1.2

1.1

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.21

1.08

1.3

1.0

—

Benign neoplasm: Spinal meninges

2.21

1.08

1.6

1.1

—

Other and unspecified disorders of white blood cells

128

1.57

1.08

1.2

1.1

—

Frostbite

2.21

1.08

1.0

1.1

—

Intentional self-harm by sharp object

105

1.63

1.06

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

710

0.78

1.06

1.1

—

56.28

—

Multiple myeloma and malignant plasma cell neoplasms

113

1.60

1.05

1.2

1.1

—

Chronic Coagulation defects

1.68

1.04

1.2

1.1

—

Failure and rejection of transplanted organs and tissues

1.98

1.04

1.0

—

Perineal laceration during delivery

823

0.81

1.03

1.0

1.1

—

67.63

—

Benign neoplasm: Skin of lower limb, including hip

1.64

1.03

1.0

1.1

—

Anorexia (incl.atypical)

280

1.36

1.03

1.0

1.1

—

Unspecified threat to breathing

2.08

1.03

1.0

1.1

—

Tibial collateral bursitis [Pellegrini-Stieda]

2.08

1.03

1.1

—

Lichen planus

411

1.29

1.03

1.1

—

85.00

—

Toxic effect of other and unspecified substances

1.93

1.02

1.2

1.1

—

Open wound of thorax

1.93

1.02

1.3

1.1

—

Malignant melanoma

438

1.28

1.02

1.1

—

39.99

—

Overjet

1.64

1.02

1.1

—

Hereditary retinal dystrophy

1.90

1.02

1.2

1.1

—

Alcoholic gastritis

1.90

1.02

1.2

1.0

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.70

1.02

1.1

—

Beningn neoplasm: Meninges, unspecified

1.89

1.01

1.1

—

Gingival hyperplasia

1.66

1.00

1.0

1.1

—

Other protozoal intestinal diseases

1.85

0.99

1.1

—

Assault by blunt object

1.85

0.99

1.1

—

Acute otitis externa, noninfective

1.85

0.99

1.0

1.1

—

1.61

0.98

1.1

—

Leukaemia of unspecified cell type

2.19

0.98

1.0

—

Social disorders starting during childhood or adolecense, excluding more controls

2.19

0.98

1.0

1.1

—

Hepatomegaly and splenomegaly, not elsewhere classified

2.19

0.98

1.2

1.0

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.98

0.0

1.1

—

Carcinoma in situ of cervix uteri, exocervix

0.00

0.98

0.0

1.1

—

Other inflammation of eyelid

450

1.27

0.97

1.1

—

62.24

—

Exposure to other and unspecified man-made environmental factors

1.87

0.97

1.0

1.1

—

Adenomyosis (Endometriosis of uterus)

504

1.25

0.97

1.2

1.1

—

57.32

—

Benign neoplasm: Duodenum

1.75

0.97

1.3

1.1

—

Other hammer toe(s) (acquired)

481

1.25

0.96

1.1

—

108.71

—

Malignant neoplasm of breast, HER-negative

670

0.79

0.96

1.0

1.1

—

104.61

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

731

1.21

0.95

1.1

—

79.29

—

Colorectal cancer

648

0.79

0.95

1.1

—

75.57

—

Flat foot [pes planus] (acquired)

302

1.33

0.95

1.1

—

110.00

—

Certain zoonotic bacterial diseases

1.78

0.95

1.2

1.1

—

Congenital malformations of uterus and cervix

1.66

0.94

1.1

—

Tarsal tunnel syndrome

1.91

0.94

1.0

1.1

—

Clear cell adenocarcinoma of kidney

133

1.51

0.94

1.1

—

Infection of intervertebral disc (pyogenic)

1.91

0.94

1.1

—

Benign neoplasm: Adrenal gland

225

1.38

0.94

1.0

1.1

—

21.14

—

Other and unspecified injuries of neck

2.24

0.94

1.2

1.1

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

2.24

0.94

1.0

1.1

—

Acute myeloid leukaemia, helper endpoint

2.24

0.94

1.0

1.1

—

Other and unspecified abdominal hernia

117

1.55

0.94

1.0

1.1

—

Motorcycle rider injured in noncollision transport accidents

109

1.57

0.93

1.1

—

Benign neoplasm: Small intestine

109

1.57

0.93

1.2

1.1

—

Endometriosis of intestine

1.73

0.93

1.0

1.1

—

Beningn neoplasm: Meninges, unspecified

1.74

0.92

1.1

1.2

—

Other and unspecified injuries of thorax

1.74

0.92

1.2

1.1

—

Acute lymphocytic leukaemia

2.17

0.92

1.2

1.1

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

280

0.68

0.92

1.1

—

27.84

—

Migraine, unspecified, drug-induced

2.17

0.92

1.0

1.1

—

Folate deficiency anaemia

2.17

0.92

1.2

1.1

—

Other congenital malformations, not elsewhere classified

2.17

0.92

1.0

1.1

—

Oral lichen ruber planus

1.68

0.92

1.1

—

Rosacea

419

1.27

0.91

1.1

—

85.00

—

Contact with sharp glass

151

1.46

0.90

1.0

1.1

—

Seminoma of testis

2.09

0.89

1.0

1.1

—

Tuberculosis

143

1.47

0.89

1.0

1.1

—

Other and unspecified disorders of psychological development

1.94

0.89

1.0

1.1

—

Allergic contact dermatitis due to drugs in contact with skin

1.70

0.89

1.2

1.1

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

105

0.47

0.88

1.0

—

Chronic periodontitis, complicated

315

1.31

0.88

1.1

—

22.02

—

Disorder of the sleep-wake schedule

1.80

0.88

1.0

1.1

—

Other specified/unspecified deforming dorsopathies

1.80

0.88

1.1

—

Benign neoplasm: Small intestine

111

1.54

0.88

1.2

1.1

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

1.59

0.87

1.3

1.1

—

Nonalcoholic steatohepatitis

2.02

0.87

1.0

1.1

—

Personal history of medical treatment

2.02

0.87

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

275

0.69

0.85

1.1

—

27.84

—

Other juvenile arthritis

167

0.60

0.85

1.1

1.0

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

1.96

0.85

1.2

1.1

—

Acute lymphocytic leukaemia, helper endpoint

1.96

0.85

1.2

1.1

—

Benign neoplasm: Pharynx, unspecified

1.96

0.85

1.3

1.2

—

Benign neoplasm: Pharynx, unspecified

1.96

0.85

1.3

1.2

—

1.95

0.85

1.0

—

Hereditary deficiency of other clotting factors

1.95

0.85

1.2

1.1

—

Assault by other specified means

1.95

0.84

1.2

1.1

—

Seminoma of testis, excluding all cancers (controls excluding all cancers)

1.95

0.84

1.0

1.1

—

Idiopathic thrombocytopenic purpura

1.57

0.84

1.0

1.1

—

Discitis, unspecified

1.79

0.84

1.0

1.1

—

Coronary atherosclerosis

252

1795

0.90

0.84

1.1

58.53

69.88

au/ml

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.77

0.84

1.1

—

Hypoplasia of dental enamel , including avohilmo

111

1.52

0.84

1.0

1.1

—

Amputation of ankle bones

1.76

0.84

1.1

—

Other eating disorders

248

1.34

0.83

1.1

1.0

—

Ulcer of lower limb, not elsewhere classified

380

1.27

0.83

1.1

—

25.86

—

Respiratory tuberculosis, confirmed and not-confirmed

129

1.48

0.83

1.0

1.1

—

Respiratory tuberculosis

129

1.48

0.83

1.0

1.1

—

Colorectal cancer, excluding all cancers (controls excluding all cancers)

794

0.83

1.1

—

52.61

—

Acidosis

1.70

0.82

1.0

1.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

146

1.44

0.82

1.1

1.0

—

Other congenital malformations of skin

146

1.44

0.82

1.0

1.1

—

Unspecified nephritic syndrome

1.65

0.82

1.1

—

Major coronary heart disease event

256

1881

0.91

0.81

1.1

55.51

72.56

au/ml

—

6-mercaptopurine

1.55

0.81

1.0

1.1

—

Carcinoma in situ of breast

0.00

0.80

0.0

1.0

—

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.1

—

Melanocytic naevi of eyelid, including canthus

1.83

0.79

1.2

1.1

—

Other disorders of iris and ciliary body

1.67

0.79

1.2

1.1

—

Fracture of neck

173

1.39

0.78

1.1

—

Unequal limb length (acquired)

0.00

0.78

0.0

1.1

—

Primary ovarian failure

1.60

0.78

1.1

—

Other articular cartilage disorders

1.63

0.78

1.1

—

Coronary revascularization (ANGIO or CABG)

149

1176

0.88

0.78

1.1

61.04

70.57

au/ml

—

Conduction disorders

118

852

1.15

0.78

1.1

—

77.29

—

Emergency coronary revascularization (for ACS)

159

1287

0.89

0.78

1.1

61.04

73.85

au/ml

—

Parodontitis and operation codes

433

3134

1.07

0.77

1.1

69.34

70.12

au/ml

—

Melanocytic naevi of eyelid, including canthus

1.78

0.76

1.2

1.1

—

Complex cardiac defects

0.00

0.76

0.0

1.1

—

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.76

0.0

1.1

—

Inflammatory disorders of male genital organs, not elsewhere classified

1.77

0.76

1.2

1.1

—

Myocardial infarction, with ST-elevation

450

0.78

0.76

1.2

1.1

—

44.69

—

Sulfonylureas

848

0.86

0.76

1.1

—

55.01

—

Helminthiases

1.71

0.76

1.1

—

Other retinal artery occlusion

1.70

0.76

1.1

—

Malignant neoplasm of breast, HER-positive

104

1182

0.87

0.75

1.2

1.1

—

89.97

—

Other and unspecified intracranial injuries

1.55

0.75

1.0

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

1.65

0.75

1.0

—

Liveborn infants according to place of birth

2.11

0.75

1.0

—

Neonatal jaundice from other and unspecified causes

1.69

0.75

1.0

—

Leukaemia of unspecified cell type

2.10

0.75

1.0

—

Gout due to impairment of renal function

2.10

0.75

1.0

1.1

—

Caught, crushed, jammed or pinched in or between objects

175

1.38

0.74

1.0

1.1

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

1.67

0.74

1.0

1.1

—

Multiple myeloma

1.67

0.74

1.0

1.1

—

Juvenile arthritis (FINNGEN)

196

0.66

0.74

1.1

—

Foreign body or object entering through skin

254

1.30

0.73

1.1

—

Acute inflammation of orbit

2.02

0.73

1.2

1.1

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.02

0.73

1.0

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

334

1.26

0.73

1.1

—

45.10

—

Contact with venomous snakes and lizards

1.81

0.73

1.1

—

Molar incisor enamel hypoplasia, with caries

2.01

0.73

1.0

—

Injury of nerves at shoulder and upper arm level

1.81

0.73

1.0

1.1

—

Other and unspecified aplastic anaemias

1.81

0.73

1.1

—

Phakomatoses, not elsewhere classified

1.81

0.73

1.0

1.1

—

Open wound of shoulder and upper arm

1.68

0.72

1.1

—

Ulcer of vagina/vulva

1.56

0.72

1.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

117

1.46

0.72

1.1

—

Unspecified human immunodeficiency virus [HIV] disease

1.76

0.71

1.0

1.2

—

Benign neoplasm: Skin of other and unspecified parts of face

335

1.26

0.71

1.1

—

21.14

—

Foreign body in ear

1.59

0.71

1.0

1.1

—

Benign neoplasm of male genital organs

1.59

0.71

1.1

—

Occupational exposure to risk-factors

109

1.47

0.71

1.1

1.0

—

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

1.94

0.71

1.0

1.1

—

Flatulence and related conditions

1.93

0.71

1.0

1.1

—

Hypoparathyroidism

101

1.49

0.70

1.1

1.2

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

1.72

0.70

1.3

1.1

—

Dermatitis herpetiformis

1.56

0.70

1.1

—

L02BG Aromatase inhibitors

987

0.86

0.69

1.1

—

89.50

—

Injury of urinary and pelvic organs

1.65

0.68

1.0

1.1

—

Pulmonary oedema

1.86

0.68

1.2

1.1

—

Valvular operations

441

0.79

0.67

1.1

—

61.05

—

Venous complications and haemorrhoids in the puerperium

1.64

0.67

1.1

—

Abscess of external ear

1.64

0.67

1.0

1.1

—

Carcinoma in situ of skin of scalp and neck

1.63

0.67

1.1

1.0

—

Other hereditary haemolytic anaemias

1.80

0.66

1.2

1.1

—

Vitamin B12 deficiency anaemia

285

1.27

0.66

1.1

—

21.14

—

Pneumoconiosis due to asbestos and other mineral fibres

1.79

0.66

1.0

1.1

—

Vascular diseases of the intestine

1.52

0.66

1.0

—

Other disorders of gingiva or/and edentulous alveolar ridge

145

1.38

0.66

1.1

—

Loose body in joint

1.55

0.65

1.0

—

Problems related to social environment

1.54

0.65

1.2

1.1

—

Special screening examination for neoplasms

1.54

0.65

1.3

1.1

—

Galactorrhea

1.60

0.65

1.1

—

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

561

0.82

0.65

1.1

—

85.93

—

Erythema intertrigo

1.58

0.65

1.2

1.1

—

Oral lichen ruber planus, hypothyreosis or thyroxin

1.60

0.65

1.0

—

Communicating hydrocephalus

1.62

0.65

1.1

1.0

—

Carcinoma in situ of skin of upper limb, including shoulder

1.60

0.65

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

331

1.24

0.65

1.1

—

20.96

—

Glaucoma secondary to eye inflammation

1.74

0.64

1.0

1.1

—

Benign neoplasm: Parathyroid gland

1.73

0.64

1.0

1.1

—

Aortic aneurysm

634

0.84

0.64

1.1

—

39.81

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

130

0.61

0.63

1.0

1.1

—

Open wound of abdomen, lower back and pelvis

112

1.43

0.63

1.1

—

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

105

966

0.88

0.62

1.2

1.1

—

71.10

—

Delayed milestone in childhood

1.56

0.62

1.0

—

Toxic liver disease

1.64

0.62

1.0

1.1

—

Benign neoplasm: Other/unspecified site

1.64

0.62

1.0

1.1

—

AV-block

451

1.19

0.62

1.1

—

60.12

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.59

0.62

1.1

—

Myeloid leukaemia

1.59

0.62

1.0

1.1

—

Other lesions of median nerve

1.59

0.62

1.0

1.1

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

222

1390

1.09

0.61

1.1

131.26

52.66

au/ml

—

Benign neoplasm: Parathyroid gland

1.68

0.61

1.0

1.1

—

Hyphaema and other vascular disorders of iris and ciliary body

1.61

0.61

1.1

—

Congenital malformations of cardiac chambers and connections

0.00

0.60

0.0

1.1

—

Pathological resorption of teeth

1.48

0.60

1.1

—

malignant neoplasm of male genital organs

113

809

0.89

0.60

1.1

52.46

56.95

au/ml

—

Use of entacapone

0.00

0.60

0.0

1.1

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.57

0.60

1.3

1.1

—

Carcinoma in situ of breast

0.00

0.60

0.0

1.0

—

Disorders of parathyroid gland, other and/or unspecified

0.00

0.60

0.0

1.0

—

1.51

0.60

1.1

1.0

—

Other dermatomyositis

0.00

0.59

0.0

1.0

—

Dental caries 2 and operation codes, only avohilmo

413

2409

1.06

0.59

1.1

28.18

80.02

au/ml

—

Discontinuity and dislocation of ear ossicles

0.00

0.59

0.0

1.2

—

Ductal carcinoma of pancreas

0.00

0.59

0.0

1.1

—

Squamous cell neoplasms and carcinoma of cervix

0.00

0.59

0.0

1.1

—

Benign neoplasm: Other/unspecified site

1.55

0.59

1.0

1.1

—

Malignant neoplasm of testis

1.55

0.59

1.0

—

Pyoderma

1.57

0.59

1.1

—

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

0.58

0.0

1.1

—

Other respiratory diseases principally affecting the interstitium

473

1.19

0.58

1.1

—

25.86

—

malignant neoplasm of female genital organs

421

0.81

0.58

1.0

1.1

—

94.19

—

Other and unspecified bullous disorders

1.73

0.58

1.0

1.1

—

Benign neoplasm of other and unspecified sites

106

1.42

0.57

1.0

1.1

—

Use of rotigotine

1.68

0.57

1.0

1.1

—

Molar incisor enamel hypoplasia

121

1.38

0.57

1.0

—

Pedestrian injured in other and unspecified transport accidents

1.68

0.57

1.0

1.1

—

Other vitreous opacities

115

1.40

0.56

1.0

1.1

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

1.51

0.56

1.1

—

Dyshidrosis [pompholyx]

1.46

0.56

1.1

—

Charcot foot

1.46

0.56

1.5

1.1

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.46

0.56

1.0

1.1

—

Malignant neoplasm, without specification of site

1.46

0.56

1.3

1.1

—

Drug-induced obesity

1.63

0.56

1.0

1.1

—

Open bite that required surgery (Lefort1 or BSSRO)

1.63

0.56

1.0

1.1

—

Carcinoma in situ of colon

1.63

0.55

1.0

1.1

—

Other specified and unspecified disorders of eyelid

1.63

0.55

1.3

1.1

—

Cholelithiasis

416

2752

1.06

0.55

1.1

46.56

78.07

au/ml

—

Alcoholic liver disease

320

1.22

0.55

1.1

—

22.02

—

Mumps

1.45

0.55

1.1

—

Benign neoplasm of other and unspecified sites

107

1.41

0.55

1.0

1.1

—

Pre-eclampsia

108

964

1.12

0.55

1.1

—

75.44

—

Malignant neoplasm of stomach

123

0.65

0.54

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

107

955

1.12

0.54

1.2

1.1

—

68.11

—

Lichen simplex chronicus

116

1.38

0.54

1.0

1.1

—

Crystal arthropathies, rheuma endpoint

1.58

0.54

1.0

—

Cholelithiasis, broad definition with cholecystitis

433

2805

1.06

0.54

1.1

46.56

78.07

au/ml

—

Tooth agenesis EXCLUDE clefts and syndromes

159

0.69

0.54

1.1

—

Lichen planus, including avohilmo

608

1.15

0.54

1.1

—

84.47

—

Corneal scars and opacities

1.49

0.53

1.0

1.1

—

HSIL lesion of the vulva

1.46

0.53

1.0

1.1

—

Pregnancy, childbirth and the puerperium

132

765

0.90

0.53

1.1

—

67.16

—

Carcinoma in situ of colon

1.55

0.53

1.0

1.2

—

Other surgical follow-up care

108

1.39

0.53

1.0

1.1

—

Other disorders of choroid

1.54

0.53

1.2

1.1

—

Acute nephritic syndrome

1.46

0.53

1.0

1.1

—

Bullous pemphigoid

1.54

0.53

1.0

1.1

—

Rare circulating lymphoid malignancy

1.43

0.53

1.2

1.1

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

294

1.22

0.53

1.0

1.1

—

24.58

—

Malignant neoplasm of colon

382

0.81

0.52

1.1

—

27.84

—

1.52

0.52

1.2

1.0

—

Prurigo nodularis

1.52

0.52

1.1

—

Psoriatic arthropathies, ICD10

405

1.19

0.52

1.0

1.1

—

72.83

—

Mild mental retardation

0.62

0.52

1.0

1.1

—

Pre-eclampsia or eclampsia

115

1035

1.11

0.52

1.1

—

75.44

—

Other/unspecified rheumatoid arthritis

378

1.19

0.52

1.1

—

73.05

—

Parapsoriasis

1.41

0.51

1.0

1.1

—

Ankyloglossia

1.41

0.51

1.0

1.1

—

Carcinoma in situ of breast, intraductal

259

0.77

0.51

1.1

—

85.00

—

Pedal cyclist injured in noncollision transport accidents

462

1.17

0.51

1.1

—

85.88

—

Congenital malformations of the respiratory system

1.39

0.50

1.1

—

Dislocation, sprain and strain of joint and ligaments of hip

1.42

0.50

1.1

—

Traumatic ischaemia of muscle

1.47

0.50

1.5

1.1

—

Other bursitis of hip

1.47

0.50

1.0

1.1

—

Distal bite

152

1.31

0.50

1.1

—

Dislocation, sprain and strain of joints and ligaments of head

162

1.30

0.50

1.0

—

Other interventions on the root canals of the tooth

1.50

0.50

1.0

1.1

—

613

0.87

0.50

1.1

—

60.38

—

Benign neoplasm: Conjunctiva

101

1.39

0.49

1.1

—

Motorcycle rider injured in other and unspecified transport accidents

243

1.24

0.49

1.0

1.1

—

Mental retardation, wide definition

167

0.72

0.49

1.0

1.1

—

Mental and behavioural disorders due to cannabinoids

136

1.33

0.49

1.1

—

Arterial embolism and thrombosis

144

0.69

0.49

1.0

1.1

—

Car occupant injured in noncollision transport accident

136

1.33

0.49

1.0

1.1

—

Wet age-related macular degeneration

339

0.81

0.49

1.0

1.1

—

36.67

—

Dislocation, sprain and strain of joints and ligaments of thorax

110

1.37

0.49

1.0

1.1

—

Filling of root of tooth

110

0.63

0.48

1.1

—

Acute bronchiolitis

227

1.23

0.48

1.0

1.1

—

Chronic hepatitis NAS

1.53

0.48

1.3

1.1

—

Syphilis

1.40

0.48

1.5

1.1

—

Intussusception

1.45

0.48

1.0

1.1

—

Other salmonella infections

119

1.35

0.48

1.0

1.1

—

Benign neoplasm: Vagina

1.50

0.47

1.1

—

Mental retardation

154

0.71

0.47

1.0

1.1

—

Poor fetal growth

645

0.87

0.47

1.0

1.1

—

46.48

—

Burn and corrosion of head and neck

1.48

0.47

1.1

—

Volvulus

1.48

0.47

1.1

1.0

—

Congenital deformities of hip

1.48

0.47

1.0

1.1

—

Gender identity disorders

1.46

0.47

1.0

1.1

—

Crushing injury of wrist and hand

1.46

0.47

1.1

—

Achalasia of cardia

1.46

0.47

1.0

1.1

—

Tuberculosis of other organs

1.46

0.47

1.1

—

Keratoconus

1.39

0.46

1.1

—

Pleural effusion

402

1.17

0.46

1.1

—

29.07

—

Pterygium

0.62

0.46

1.2

1.1

—

Open wound of hip and thigh

119

0.67

0.45

1.4

1.1

—

Anxious personality disorder

1.43

0.45

1.0

1.1

—

Acute epiglottitis

1.40

0.45

1.0

1.1

—

Other psoriatic arthropathies

394

1.17

0.44

1.0

1.1

—

72.83

—

Retained placenta and membranes, without haemorrhage

507

1.15

0.44

1.1

—

102.17

—

Lactose intolerance, other/unspecified

1.37

0.44

1.0

1.1

—

Direct fill therapy

545

1.14

0.43

1.1

—

41.88

—

Human immunodeficiency virus [HIV] disease

1.42

0.43

1.1

—

Mixed disorders of conduct and emotions

104

1.35

0.43

1.1

—

Hodgkin lymphoma, hilmo

104

1.35

0.43

1.1

—

Other menopausal disorders

132

696

1.09

0.43

1.0

1.1

—

77.32

—

Exposure to smoke, fire and flames

1.42

0.43

1.1

—

Impacted maxillary canine

1.62

0.43

1.2

1.1

—

Postdysenteric arthropathy

1.62

0.43

1.0

1.1

—

Palindromic rheumatism

1.62

0.43

1.0

1.1

—

Spondylopathies in diseases classified elsewhere

1.62

0.43

1.0

1.1

—

Adult respiratory distress syndrome

1.62

0.43

1.2

1.1

—

Benign neoplasm: Short bones of upper limb

1.43

0.42

1.0

1.1

—

Haemangioma, any site

285

1.19

0.42

1.0

1.1

—

21.14

—

Social disorders starting during childhood or adolescence

1.57

0.42

1.0

1.1

—

Scissor bite

104

1.35

0.42

1.1

—

Unspecified chronic bronchitis

0.66

0.42

1.2

1.1

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

1.57

0.42

1.0

1.1

—

Exophthalmic conditions

1.57

0.42

1.0

1.1

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.41

0.42

1.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

1.44

0.42

1.1

—

Pure hyperglyceridaemia

1.43

0.42

1.2

1.0

—

Myeloid leukaemia

1.43

0.42

1.0

1.1

—

Benign neoplasm: Short bones of upper limb

1.38

0.41

1.0

1.1

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.41

0.0

1.2

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.41

0.0

1.0

—

Malignant neoplasm of gum

0.00

0.41

0.0

1.0

—

Peripheral artery operations in Hilmo

304

1.18

0.41

1.1

—

24.58

—

Other and unspecified atrophic disorders of skin

0.00

0.41

0.0

1.0

—

Acute hepatitis B

0.00

0.41

0.0

1.2

—

Other disorders of amino-acid metabolism

0.00

0.41

0.0

1.1

—

Paget disease

0.00

0.41

0.0

1.0

—

Familial erythrocytosis

0.00

0.41

0.0

1.1

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

0.41

0.0

1.1

—

Interstitial cystitis (chronic), drug-induced

0.00

0.41

0.0

1.1

—

Lumbosacral root disorders, not elsewhere classified

1.52

0.41

1.0

—

Gastrojejunal ulcer

1.52

0.41

1.0

1.1

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.41

0.0

1.0

—

Malignant neoplasm of base of tongue

0.00

0.41

0.0

1.1

—

Wilms' tumor, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.2

—

Contact with blunt object, undetermined intent

0.00

0.41

0.0

1.2

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.41

0.0

1.1

—

Adjustment and management of implanted device

463

1.15

0.41

1.1

—

62.15

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.36

0.41

1.0

—

Other or unspecified immunodeficiency

0.00

0.41

0.0

1.1

—

Assault by unspecified means

1.40

0.41

1.1

—

HSIL lesion of the cervix uteri

931

0.90

0.41

1.0

1.1

—

75.89

—

Benign neoplasm: Other parts of oropharynx

1.48

0.40

1.0

1.1

—

Pigmented purpuric dermatosis

1.48

0.40

1.0

1.1

—

Morphin

1.47

0.40

1.0

1.1

—

Other melanin hyperpigmentation

1.34

0.40

1.0

1.1

—

Carcinoma in situ of skin of trunk

1.34

0.40

1.3

1.0

—

Acquired keratosis [keratoderma] palmaris et plantaris

0.00

0.40

0.0

1.1

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.1

—

Contusion of ankle

150

1.27

0.40

1.2

1.0

—

Rhinophyma

0.00

0.40

0.0

1.1

—

Unattended death

0.00

0.40

0.0

1.1

—

Other, unspecified and serous retinal detachments

1.37

0.40

1.2

1.1

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

652

0.91

0.39

1.1

72.86

25.65

au/ml

—

Pemphigoid

1.31

0.39

1.0

1.1

—

Benign neoplasm: Other parts of oropharynx

1.44

0.39

1.0

1.1

—

Inflammation of lacrimal passages (chronic)

1.43

0.39

1.2

1.0

—

Carcinoma in situ of vagina

0.00

0.39

0.0

1.2

—

Burn and corrosion, body region unspecified

0.00

0.39

0.0

1.2

—

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.1

—

ILD medications: pirfenidone

0.00

0.39

0.0

1.1

—

Gestational [pregnancy-induced] hypertension

143

1323

1.08

0.38

1.1

—

62.64

—

Other and unspecified iridocyclitis

142

1.27

0.38

1.0

1.1

—

Gonarthrosis,primary

401

2410

1.05

0.38

1.1

31.68

80.95

au/ml

—

Polyhydramnios

224

1.21

0.38

1.1

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

1.39

0.38

1.0

1.1

—

Evidence of alcohol involvement determined by level of intoxication

1.39

0.38

1.0

1.1

—

Schizoid personality disorder

1.35

0.38

1.0

1.1

—

Other specific arthropathies, wide

1.35

0.38

1.0

1.1

—

Injury of muscle and tendon at hip and thigh level

354

1.16

0.38

1.2

1.1

—

73.78

—

Pollen allergy

108

980

1.09

0.38

1.1

—

71.63

—

Hyperkinetic disorders (excl. ADHD)

1.40

0.37

1.2

1.1

—

Autism spe, excluding more controls

1.33

0.37

1.0

1.1

—

Pregnancy hypertension

230

1956

1.06

0.37

1.1

—

67.43

—

Contact with other sharp object(s)

280

1.18

0.37

1.2

1.1

—

Parodontitis or operation codes

452

3194

1.04

0.37

1.1

69.34

70.12

au/ml

—

Ovarian hyperstimulation (induction)

1.31

0.37

1.0

1.1

—

Other congenital malformations of female genitalia

1.36

0.37

1.0

1.1

—

Osteonecrosis due to drugs

1.36

0.37

1.0

1.1

—

Benign neoplasm: Oesophagus

1.36

0.37

1.0

1.1

—

Benign neoplasm: Oesophagus

1.36

0.37

1.0

1.1

—

Noise effects on inner ear

134

1.27

0.37

1.2

1.1

—

Mucosal proctocolitis

553

1.12

0.37

1.1

—

85.88

—

Other disorders of breast and lactation associated with childbirth

1.29

0.36

1.1

—

Chronic mastoiditis

1.29

0.36

1.0

1.1

—

Contusion of other and unspecified parts of foot

207

1.21

0.36

1.1

—

Haemangioma and lymphangioma, any site

309

1.17

0.36

1.0

1.1

—

50.78

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

0.66

0.36

1.0

1.1

—

Scabies

171

1.23

0.35

1.2

1.1

—

Infection due to other mycobacteria

1.43

0.35

1.2

1.0

—

Other crystal arthropathies

1.43

0.35

1.0

—

Melanoma in situ

1.32

0.35

1.2

1.1

—

Parodontitis

451

3195

1.04

0.35

1.1

69.34

70.12

au/ml

—

Sequelae of other accidents

1.40

0.35

1.0

1.1

—

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

1.40

0.35

1.0

1.1

—

Amputation of thigh

1.40

0.35

1.0

1.1

—

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

255

0.82

0.35

1.0

1.1

—

68.92

—

Burns and corrosions of multiple and unspecified body regions

1.37

0.34

1.1

—

Benign neoplasm of mouth and pharynx

358

1.15

0.34

1.1

—

43.21

—

Varicose veins

240

1911

0.95

0.34

1.1

76.26

77.90

au/ml

—

Chronic periodontitis, including avohilmo

448

3190

1.04

0.33

1.1

69.34

70.12

au/ml

—

Suppurative otitis media, unspecified

100

1.30

0.33

1.0

1.1

—

Laparoscopic right hemicolectomy

144

0.76

0.33

1.1

—

Idiopathic urticaria

0.70

0.33

1.0

1.1

—

Family history of other specific disorders

1.31

0.33

1.0

1.1

—

Benign neoplasm: Other and unspecified parts of small intestine

1.31

0.33

1.2

1.1

—

Benign neoplasm: Other and unspecified parts of small intestine

1.31

0.33

1.2

1.0

—

Enteropathic arthropathies

0.70

0.33

1.0

1.1

—

Melanocytic naevi of scalp and neck

0.66

0.33

1.0

1.1

—

Other and unspecified disease of Bartholin gland

0.66

0.33

1.0

1.1

—

Carcinoma in situ of other and unspecified digestive organs

1.36

0.32

1.0

1.1

—

Other assisted single delivery

1.33

0.32

1.0

—

Perioral dermatitis

1.33

0.32

1.0

1.1

—

Other congenital malformations of peripheral vascular system

1.35

0.31

1.0

1.1

—

All dysplastic lesions of the cervix uteri

126

1346

0.93

0.31

1.1

—

68.30

—

Acne

522

1.11

0.31

1.2

1.1

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.70

0.31

1.1

—

LSIL lesion of the vagina

1.33

0.31

1.0

1.1

—

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

527

0.89

0.31

1.1

—

48.76

—

Disorders of puberty

1.30

0.30

1.3

1.1

—

Benign neoplasm: Vagina

1.28

0.30

1.1

—

Hodgkin lymphoma

111

1.26

0.30

1.1

—

Toxic effect of carbon monoxide

1.28

0.30

1.0

1.1

—

Cardiomyopathy, other and unspecified

259

1.16

0.29

1.0

1.1

—

27.65

—

Poisoning by medicine, drug-induced

1.25

0.29

1.0

1.1

—

Other blood glucose lowering drugs, excl. Insulins

496

1.11

0.29

1.2

1.1

—

76.06

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

185

1.19

0.29

1.1

—

85.00

—

Nephrotic syndrome

106

0.75

0.29

1.1

—

Cystic kidney disease

107

0.75

0.29

1.1

—

Asymmetry of jaw

1.23

0.29

1.0

1.1

—

Alcohol abuse counselling and surveillance

1.23

0.29

1.0

1.1

—

Cerebral palsy

1.23

0.29

1.1

—

Other secondary coxarthrosis

109

0.73

0.29

1.0

1.1

—

Benign neoplasm: Rectosigmoid junction

110

0.73

0.29

1.3

1.1

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

291

0.86

0.28

1.2

1.1

—

29.07

—

Chondromalacia

103

1.27

0.28

1.2

1.1

—

Acute posthaemorrhagic anaemia

1.32

0.28

1.0

1.1

—

ILD, hospital admissions

393

1.12

0.28

1.1

—

27.84

—

Disorders of puberty, all

1.27

0.28

1.3

1.1

—

conjunctival degenerations and deposits

1.27

0.28

1.0

1.1

—

Left hemicolectomy

1.27

0.28

1.3

1.1

—

Chromosomal abnormalities, not elsewhere classified

1.32

0.27

1.1

—

Disorders of globe

1.25

0.27

1.0

1.1

—

Colectomy operation

522

0.90

0.27

1.1

—

54.79

—

Hypertensive Heart Disease

525

1.09

0.27

1.1

—

66.13

—

Other and unspecified nail disorders

1.21

0.26

1.3

1.1

—

Malignant neoplasm of other connective and soft tissue

1.21

0.26

1.0

1.1

—

Suppurative and necrotic conditions of lower respiratory tract

159

1.20

0.26

1.1

—

Fall involving bed

1.20

0.26

1.0

1.1

—

ILD, hospital admissions 1, main diag only

357

1.12

0.26

1.1

—

27.65

—

Angina pectoris

223

1575

0.96

0.26

1.1

114.60

74.13

au/ml

—

Systemic sclerosis

1.30

0.26

1.1

—

Femoral hernia, unilateral

1.30

0.26

1.0

1.1

—

Inguinal hernia, unilateral

1.30

0.26

1.0

1.1

—

Inguinal of femoral hernia, unilateral

1.30

0.26

1.0

1.1

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.68

0.26

1.0

1.1

—

Benign neoplasm of mouth and pharynx

367

1.12

0.26

1.1

—

21.86

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

453

1.10

0.25

1.1

—

19.39

—

Benign neoplasm: Pancreas

1.25

0.25

1.1

—

Pleural plaque

224

0.85

0.25

1.0

1.1

—

63.98

—

Benign neoplasm: Pancreas

1.20

0.25

1.1

—

Torsion of testis

1.19

0.24

1.0

1.1

—

Erythema multiforme

1.19

0.24

1.0

1.1

—

Congenital deformities of feet

1.25

0.24

1.1

—

Use of levodopa decarbox-comt-inhibitor

1.17

0.24

1.0

1.1

—

Short stature, not elsewhere classified

1.25

0.24

1.2

1.1

—

Melanocytic naevi of scalp and neck

0.73

0.24

1.0

1.1

—

Disorders of continuity of bone

350

1.12

0.24

1.1

—

85.00

—

Erectile dysfunction

208

1.16

0.24

1.2

1.1

—

24.58

—

Interstitial lung disease endpoints

398

1.11

0.24

1.1

—

27.84

—

Other interstitial pulmonary diseases

398

1.11

0.24

1.1

—

27.84

—

Interstitial lung disease

398

1.11

0.24

1.1

—

27.84

—

Early complications of trauma

152

1.19

0.23

1.3

1.1

—

!Aliquae complicationes praecoces traumatis

152

1.19

0.23

1.3

1.1

—

Benign neoplasm: Scapula and long bones of upper limb

1.32

0.23

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.32

0.23

1.2

1.1

—

Benign neoplasm: Other and unspecified parts of mouth

106

1.23

0.23

1.1

—

Benign neoplasm: Other and unspecified parts of mouth

106

1.23

0.23

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

991

0.94

0.23

1.0

1.1

—

75.89

—

Striae atrophicae

1.29

0.23

1.0

1.1

—

Ulcerative enterocolitis

125

0.80

0.23

1.0

1.1

—

Other disorders of bone density and structure

1.25

0.22

1.0

1.1

—

Thoracic aortic aneurysm

390

1.10

0.22

1.1

—

51.56

—

Myotonic disorders

1.25

0.22

1.0

1.1

—

Injury of intra-abdominal organs

0.77

0.22

1.1

—

Blood alcohol or alcohol intoxication level

0.75

0.22

1.0

1.1

—

Benign neoplasm: Skin of lip

1.25

0.22

1.0

1.1

—

Isolated proteinuria

0.75

0.22

1.1

—

Complications associated with artificial fertilization

1.27

0.22

1.2

1.1

—

Fracture of femur

621

0.93

0.22

1.1

—

48.67

—

Congenital malformations of eye, ear, face and neck

276

1.12

0.22

1.0

1.1

—

Disorders resulting from impaired renal tubular function

116

1.21

0.22

1.1

—

Respiratory tuberculosis, confirmed

1.22

0.22

1.0

1.1

—

Malignant neoplasm of skin

215

1555

1.04

0.22

1.1

131.60

61.30

au/ml

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

158

1142

0.95

0.22

1.1

131.26

52.66

au/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

468

1.09

0.21

1.0

1.1

—

63.09

—

Aortic arch syndrome [Takayasu]

0.00

0.21

0.0

1.0

—

Haematosalpinx/Haematoma of broad ligament

0.00

0.21

0.0

1.1

—

Hyperchylomicronaemia

0.00

0.21

0.0

1.1

—

Pedestrian injured in collision with pedal cycle

107

1.22

0.21

1.1

—

Need for immunization against single bacterial diseases

0.00

0.21

0.0

1.2

—

Use of selegiline

124

0.81

0.21

1.2

1.1

—

Drug-induced thyroiditis

0.00

0.21

0.0

1.0

—

Noninfective disorders of pinna

0.00

0.21

0.0

1.0

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

0.21

0.0

1.1

—

Fetus and newborn affected by other complications of labour and delivery

0.00

0.21

0.0

1.2

—

Primary gonarthrosis, bilateral

183

1534

1.04

0.21

1.1

—

80.67

—

Other leukaemias of specified cell type

0.00

0.21

0.0

1.0

—

Airway disease due to specific organic dust

0.00

0.21

0.0

1.0

—

Lordosis

0.00

0.21

0.0

1.3

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

0.00

0.21

0.0

1.1

—

Melanoma in situ, other sites/unspecified

0.00

0.21

0.0

1.0

—

Other secondary gout

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.21

0.0

1.0

—

Secondary systemic amyloidosis

0.00

0.21

0.0

1.1

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.21

0.0

1.3

—

Exposure to controlled fire, not in building or structure

0.00

0.21

0.0

1.0

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.21

0.0

1.0

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.21

0.0

1.2

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.21

0.0

1.0

—

Hypertrophy of bone

0.00

0.21

0.0

1.3

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.21

0.0

1.0

—

Rheumatic fever without mention of heart involvement

0.00

0.21

0.0

1.2

—

Generalized pustular psoriasis

0.00

0.21

0.0

1.1

—

Erectile dysfunction, exclusion

0.00

0.21

0.0

1.1

—

Benign neoplasm: Floor of mouth

0.00

0.21

0.0

1.3

—

Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced

0.00

0.21

0.0

1.1

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.2

—

Benign neoplasm: Scrotum

0.00

0.21

0.0

1.1

—

Central retinal artery occlusion

1.19

0.21

1.0

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.21

0.0

1.2

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.21

0.0

1.2

—

Alcoholic cardiomyopathy

0.00

0.21

0.0

1.2

—

ILD medications: acetylcysteine

0.00

0.21

0.0

1.1

—

Chronic respiratory disease originating in the perinatal period

0.00

0.21

0.0

1.2

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.0

—

Benign neoplasm: Urinary organ, other/unspecified

0.00

0.21

0.0

1.0

—

Chondrosarcoma

0.00

0.21

0.0

1.0

—

Benign neoplasm: Mediastinum

0.00

0.21

0.0

1.0

—

Henoch-Schönlein purpura nephritis (HSPN)

0.00

0.21

0.0

1.1

—

Atrioventricular septal defect

0.00

0.21

0.0

1.0

—

Complications specific to multiple gestation

0.00

0.21

0.0

1.0

—

Malignant neoplasm of gallbladder

0.00

0.21

0.0

1.0

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.21

0.0

1.0

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.21

0.0

1.3

—

Malignant neoplasm of floor of mouth

0.00

0.21

0.0

1.1

—

Deaf mutism, not elsewhere classified

0.00

0.21

0.0

1.1

—

ILD medications: nintedanib

0.00

0.21

0.0

1.1

—

Mandibular retrognathia AND surgery (BSSRO)

102

0.78

0.21

1.0

1.1

—

Benign neoplasm: Scapula and long bones of upper limb

1.16

0.21

1.0

1.1

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.16

0.21

1.0

1.1

—

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Benign neoplasm: Mediastinum

0.00

0.21

0.0

1.0

—

Other and unspecified water transport accidents

0.00

0.21

0.0

1.3

—

Livedoid vasculitis

0.00

0.21

0.0

1.0

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.21

0.0

1.0

—

Wilms' tumor

0.00

0.21

0.0

1.2

—

Medical treatment for female infertility

111

1168

0.95

0.21

1.1

—

84.42

—

Benign neoplasm: Larynx

1.24

0.21

1.1

—

Systemic sclerosis, icd10

1.25

0.20

1.1

—

Benign neoplasm: Anus and anal canal

1.25

0.20

1.3

1.1

—

Unstable angina pectoris

115

1004

0.95

0.20

1.1

82.64

72.63

au/ml

—

Fitting and adjustment of external prosthetic device

0.00

0.20

0.0

1.1

—

Cleft lip

0.00

0.20

0.0

1.1

—

Other specified and unspecified disorders of iris and ciliary body

0.00

0.20

0.0

1.1

—

Chronic thyroiditis

0.00

0.20

0.0

1.2

—

Carcinoma in situ of vagina

0.00

0.20

0.0

1.2

—

Vitiligo

1.25

0.20

1.2

1.1

—

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.0

—

Deep bite that required surgery

1.25

0.20

1.2

1.1

—

Family history of other conditions

1.25

0.20

1.2

1.1

—

Precocious puberty

0.00

0.20

0.0

1.1

—

Other and unspecified injuries of abdomen, lower back and pelvis

1.23

0.20

1.0

1.1

—

Universal erythroderma, KELA reimbursement

1.20

0.19

1.0

1.1

—

Hypersensitivity pneumonitis due to organic dust

1.20

0.19

1.3

1.1

—

Other and unspecified acne

1.18

0.19

1.5

1.1

—

Rheumatic valve diseases

1.18

0.19

1.0

1.1

—

CR(E)ST syndrome

1.16

0.19

1.0

1.1

—

Contact with sharp object, undetermined intent

1.24

0.19

1.0

1.1

—

Other disorders of prostate

1.24

0.18

1.0

1.1

—

Unspecified lump in breast

599

1.07

0.18

1.1

—

104.81

—

Assault by sharp object

1.21

0.18

1.1

—

Other congenital malformations of tongue, mouth and pharynx

1.20

0.18

1.0

1.1

—

Non-ischemic cardiomyopathy

788

0.95

0.18

1.1

—

56.55

—

Hypertrophy of breast

734

0.94

0.18

1.1

—

88.43

—

Puerperal sepsis

493

1.08

0.17

1.0

1.1

—

102.17

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

119

1.18

0.17

1.1

—

Hypertensive heart and/or renal disease

570

1.06

0.17

1.1

—

66.13

—

Postpartum hemorraghe, parous women as controls

139

1167

1.04

0.17

1.1

—

67.90

—

Other specified congenital malformation syndromes affecting multiple systems

1.13

0.17

1.0

1.1

—

Embedded and impacted teeth

155

1267

1.04

0.17

1.1

—

41.90

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.11

0.17

1.1

—

Contact with lifting and transmission devices, not elsewhere classified

1.11

0.17

1.0

1.1

—

Need for immunization against other single viral diseases

0.76

0.17

1.0

1.1

—

Other and unspecified mental retardation

0.74

0.17

1.0

1.1

—

Viral agents as the cause of diseases classified to other chapters

1.16

0.16

1.0

1.1

—

Macular cyst

1.14

0.16

1.0

—

Juvenile osteochondrosis

130

0.84

0.16

1.0

1.1

—

Superficial injury of neck

1.21

0.15

1.3

1.1

—

COPD-related respiratory insufficiency

293

1.09

0.15

1.2

1.1

—

23.70

—

Benign neoplasm: Anus and anal canal

1.21

0.15

1.3

1.1

—

Dysplasia of cervi uteri

129

959

1.04

0.15

1.1

—

71.29

—

Hordeolum and other deep inflammation of eyelid

197

1.12

0.15

1.1

—

Exclusion endpoint for clefts

1.14

0.15

1.0

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

630

1.05

0.15

1.1

—

43.39

—

Gonococcal infection

129

0.85

0.14

1.0

—

Ischemic heart diseases

347

2124

1.02

0.14

1.1

78.50

69.88

au/ml

—

Postpartum haemorrhage due to anatomy

533

0.94

0.14

1.0

1.1

—

46.48

—

Iron deficiency

1.09

0.14

1.0

1.1

—

Benign neoplasm of middle ear and respiratory system

244

0.90

0.14

1.1

—

22.45

—

Benign neoplasm: Larynx

1.18

0.14

1.1

—

COPD, early/later onset

141

1233

0.96

0.14

1.1

—

70.37

—

Other congenital malformations of the digestive system

168

1.13

0.14

1.0

1.1

—

Nontoxic single thyroid nodule

223

0.90

0.14

1.1

—

85.00

—

Left bundle-branch block

208

1.11

0.14

1.2

1.1

—

27.65

—

Injury of muscle and tendon at ankle and foot level

1.19

0.14

1.0

1.1

—

Alcohol-induced acute pancreatitis

132

1.14

0.13

1.1

—

Atopic conjunctivitis

159

0.88

0.13

1.1

—

Effects of other external causes

113

1.15

0.13

1.0

1.1

—

Lactose intolerance

113

1.15

0.13

1.0

1.1

—

Valvular heart disease excluding rheumatic fever

182

1368

0.97

0.13

1.1

—

77.85

—

Family history of malignant neoplasm

448

0.94

0.13

1.0

1.1

—

102.17

—

Basal cell carcinoma

175

1434

0.97

0.12

1.1

131.26

65.78

au/ml

—

1.16

0.12

1.0

—

Postpartum hemorraghe, all women as controls

139

1342

1.03

0.12

1.1

—

68.14

—

Pyothorax

124

1.13

0.11

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

484

1.05

0.11

1.0

1.1

—

73.05

—

Other obstructive and reflux uropathy

153

1.11

0.11

1.0

—

Secondary right heart disease

1.15

0.10

1.4

1.1

—

Migraine with aura, drug-induced

1.14

0.10

1.0

1.1

—

Personal history of allergy to drugs, medicaments and biological substances

1.14

0.10

1.0

—

Benign neoplasm: Skin of lip

1.14

0.10

1.0

1.1

—

Carcinoma in situ of skin of lower limb, including hip

1.14

0.10

1.0

—

Unspecified maternal hypertension

1.11

0.10

1.0

1.1

—

Carcinoma in situ of cervix uteri, endocervix

1.11

0.10

1.0

1.1

—

Respiratory disorders in diseases classified elsewhere

1.11

0.10

1.2

1.1

—

Corneal degeneration

1.11

0.10

1.0

1.1

—

Carcinoma in situ of skin of lower limb, including hip

1.11

0.10

1.0

1.1

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.11

0.10

1.0

1.1

—

Spinal enthesopathy

1.11

0.09

1.0

1.1

—

Other pulmonary heart/vessel disease

106

1.13

0.09

1.3

1.1

—

Contusion of toe(s) with damage to nail

1.09

0.09

1.0

1.1

—

Localized scleroderma [morphea]

1.09

0.09

1.0

1.1

—

Perichondritis of external ear

1.09

0.09

1.6

1.1

—

414

1.05

0.09

1.1

—

61.29

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

1.06

0.09

1.0

1.1

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.05

0.09

1.0

1.1

—

Carcinoma in situ of cervix uteri, endocervix

1.04

0.09

1.0

1.1

—

COPD, hospital admissions

141

1223

0.98

0.09

1.1

—

70.37

—

Inguinal hernia

270

1852

0.98

0.09

1.1

64.22

58.50

au/ml

—

Schizotypal disorder

1.14

0.09

1.0

1.1

—

COPD

150

1208

1.02

0.09

1.1

—

73.25

—

Failed attempted abortion

1.11

0.09

1.0

1.1

—

Dissocial personality disorder

1.11

0.09

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

1.11

0.09

1.2

1.1

—

Malignant neoplasm of small intestine

1.07

0.08

1.0

1.1

—

Other congenital malformations of ear

1.05

0.08

1.0

1.1

—

L01XE Protein kinase inhibitors

175

0.91

0.08

1.0

1.1

—

Major anomalies of jaw size

113

0.88

0.08

1.0

1.1

—

Cleft lip, lip and palate or palate

0.77

0.08

1.0

1.1

—

Benign neoplasm: Lip

0.77

0.08

1.0

1.1

—

Benign neoplasm: Lip

0.77

0.08

1.0

1.1

—

Mental retardation, excluding more controls

121

0.89

0.08

1.0

1.1

—

Generalized epilepsy, strict definition

1.14

0.08

1.0

1.1

—

Benign neoplasm: Skin of upper limb, including shoulder

1.06

0.08

1.0

1.1

—

Labour and delivery complicated by fetal stress [distress]

143

975

0.98

0.08

1.2

1.1

—

94.00

—

Other conjunctival vascular disorders and cysts

0.86

0.07

1.0

1.1

—

Use of rasagiline

0.86

0.07

1.0

1.1

—

ILD-related respiratory insufficiency

0.83

0.07

1.3

1.1

—

Toxic effect of alcohol

0.82

0.07

1.2

1.1

—

Dissection of aorta

1.05

0.07

1.0

—

Dependent personality disorder

1.03

0.07

1.1

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

1.03

0.07

1.0

1.1

—

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

0.85

0.07

1.1

—

Carcinoma in situ, bladder

0.85

0.07

1.0

—

Congenital malformations of great arteries

0.84

0.07

1.0

1.1

—

Arterial embolism and thrombosis of lower extremity artery

0.84

0.07

1.0

—

Juvenile rheumatoid arthirtis

0.83

0.07

1.1

—

1.13

0.07

1.0

—

Benign neoplasm: Tongue

1.07

0.07

1.2

1.1

—

LSIL lesion of the cervix uteri, vagina or vulva

669

1.03

0.07

1.0

1.1

—

89.57

—

Non-rheumatic valve diseases

181

1344

0.98

0.07

1.1

—

77.85

—

Campylobacter enteritis

1.06

0.07

1.1

—

Post-traumatic wound infection, not elsewhere classified

1.05

0.07

1.0

1.1

—

Hyperaldosteronism

1.05

0.07

1.1

—

Benign neoplasm: Tongue

1.05

0.07

1.2

1.1

—

COPD related to multimorbidity

114

981

0.98

0.06

1.1

—

63.62

—

Premature separation of placenta [abruptio placentae]

0.85

0.06

1.1

—

Crowding of teeth, including avohilmo

365

1.04

0.06

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

147

1487

0.98

0.06

1.0

1.1

—

62.64

—

Psoriasis (vulgaris), strict definition

109

1.10

0.06

1.1

—

Pre-eclampsia or poor fetal growth

162

1590

1.02

0.06

1.1

—

62.64

—

Hypertrophy of breast in women and men

840

0.98

0.06

1.1

—

88.43

—

Malignant neoplasm of mesothelium and soft tissue

121

0.91

0.06

1.1

—

Macular pucker

385

0.96

0.05

1.0

1.1

—

56.50

—

In situ neoplasms

133

1307

1.02

0.05

1.1

—

80.46

—

Toxic effect of contact with venomous animals

151

0.93

0.05

1.1

—

Contusion of toe(s) without damage to nail

100

1.10

0.05

1.0

1.1

—

Other acute skin changes due to ultraviolet radiation

110

0.91

0.05

1.0

1.1

—

Other congenital malformations of face and neck

110

1.09

0.05

1.0

1.1

—

Postpartum haemorrhage

139

1193

1.01

0.04

1.1

—

67.50

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

362

0.97

0.04

1.1

—

121.08

—

Benign neoplasm of thyroid gland

111

1.08

0.04

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

171

1365

0.99

0.04

1.1

131.60

64.22

au/ml

—

Pedal cyclist injured in collision with motor vehicle

119

0.92

0.04

1.0

1.1

—

COPD, hospital admission 2, with asthma infections

789

1.02

0.03

1.1

—

67.66

—

Other chronic obstructive pulmonary disease

141

1158

1.01

0.03

1.1

—

73.25

—

Abnormal findings on examination of urine, without diagnosis

141

1.06

0.03

1.1

—

Basal cell carcinoma, including avohilmo

184

1463

0.99

0.03

1.1

131.26

63.85

au/ml

—

Bulimia nervosa (incl. atypical)

161

1.06

0.03

1.1

—

Toxic effect of ethanol

161

1.06

0.03

1.0

1.1

—

Acute alcohol intoxication ICD-9

108

0.93

0.03

1.0

—

Contact with other hot fluids

112

1.07

0.03

1.1

—

Asthma and opportunity respiratory infection

118

0.93

0.02

1.1

—

Mixed specific developmental disorders

1.08

0.02

1.1

—

Cirrhosis of liver, NAS

152

1.05

0.02

1.1

—

Olecranon bursitis

158

0.95

0.02

1.1

—

Other and/or unspecified nontoxic goitre

252

1.03

0.02

1.0

1.1

—

85.00

—

Disorders of eyelid in diseases classified elsewhere

107

0.93

0.02

1.0

1.1

—

Benign mammary dysplasia

472

1.02

0.01

1.1

—

104.61

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

167

1156

0.99

0.01

1.1

131.26

52.66

au/ml

—

Cholangitis (primary sclerosing, PSC)

173

1.04

0.01

1.0

1.1

—

In situ neoplasms

133

1277

0.99

0.01

1.1

—

52.93

—

Desensitization to allergens

243

1.03

0.01

1.4

1.1

—

Benign neoplasm of thyroid gland

114

1.05

0.00

1.0

1.1

—

Femoral hernia

124

1.05

0.00

1.0

1.1

—

Allergic colitis

1.06

0.00

1.0

1.1

—

Ischaemic heart disease, wide definition

331

2075

1.00

0.00

1.1

78.50

69.88

au/ml

—

Simple and mucopurulent chronic bronchitis

106

1.04

0.00

1.3

1.1

—

Benign neoplasm of urinary organs

129

1.01

0.00

1.2

1.1

—

Struck by thrown, projected or falling objec

185

1.03

0.00

1.2

1.1

—

Benign neoplasm: Kidney

1.01

0.00

1.2

1.1

—

Right hemicolectomy

151

0.99

0.00

1.1

—

Abnormalities of forces of labour

475

1.01

0.00

1.0

1.1

—

101.90

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

128

1.01

0.00

1.0

1.1

—

Later onset COPD, excluding more controls

339

0.99

0.00

1.1

—

58.14

—

Disorders of tooth development and eruption

215

1.00

0.00

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

172

1183

1.00

0.00

1.1

131.26

52.66

au/ml

—

Traumatic amputation of wrist and hand

129

1.01

0.00

1.1

—

LSIL lesion of the cervix uteri

549

1.00

0.00

1.1

—

102.17

—

Contact with nonpowered hand tool

162

0.99

0.00

1.1

—

Ankylosing spondylitis, strict definition

188

1.01

0.00

1.0

1.1

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.0

1.2

—

Changes in corneal membranes

0.00

0.0

1.0

—

Hereditary factor VIII deficiency

0.00

0.0

1.0

—

Erythema annulare centrifugum

0.00

0.0

1.0

—

Carcinoma in situ of larynx

0.00

0.0

1.2

—

Lipodystrophy, not elsewhere classified

0.00

0.0

1.3

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.0

—

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.0

1.0

—

Dengue fever [classical dengue]

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.93

0.00

1.0

1.1

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.0

1.0

—

Acne varioliformis

0.00

0.0

1.4

—

Abnormal findings in peritoneal fluid saliva

0.00

0.0

1.1

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

1.0

—

Other leukaemias of specified cell type

0.00

0.0

1.0

—

Pediculosis and phthiriasis

0.00

0.0

1.0

—

Turner's syndrome

0.00

0.0

1.3

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.0

1.2

—

Early syphilis

1.02

0.00

1.4

1.1

—

Carcinoma in situ of penis

0.00

0.0

1.1

—

Autism spe

1.01

0.00

1.0

1.1

—

Pemphigus vulgaris

0.00

0.0

1.0

—

Exposure to ignition or melting of other clothing and apparel

0.00

0.0

1.1

—

Nutritional marasmus

0.00

0.0

1.0

—

Other localized connective tissue disorders

0.98

0.00

1.0

1.1

—

Cystic fibrosis, other manifestations/unspecified

0.00

0.0

1.0

—

Polydactyly

0.00

0.0

1.2

—

Other congenital malformations of eye

0.00

0.0

1.0

—

Hirsprung

0.00

0.0

1.0

—

Osteogenesis imperfecta

0.00

0.0

1.3

—

Nezelof syndrome

0.00

0.0

1.3

—

Benign neoplasm: Urethra

0.00

0.0

1.2

—

Traumatic amputation of ankle and foot

0.00

0.0

1.4

—

Traumatic secondary and recurrent haemorrhage

0.00

0.0

1.0

—

Autism

0.96

0.00

1.0

1.1

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.0

—

Fracture of spine, level unspecified

0.00

0.0

1.0

—

Malignant neoplasm of vagina

0.00

0.0

1.0

—

Cardiomyopathy due to drugs and other external agents

0.00

0.0

1.0

—

Injury of blood vessels at shoulder and upper arm level

0.00

0.0

1.0

—

Benign neoplasm: Ciliary body

0.00

0.0

1.0

—

Fractures involving multiple body regions

0.00

0.0

1.3

—

Injury of blood vessels at ankle and foot level

0.00

0.0

1.0

—

Crushing injury of head

0.00

0.0

1.0

—

Benign neoplasm: Ciliary body

0.00

0.0

1.0

—

Benign neoplasm: Skin of upper limb, including shoulder

1.01

0.00

1.0

1.1

—

Traumatic amputation of part of head

0.00

0.0

1.0

—

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.0

1.0

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.4

—

Malignant neoplasm of trachea, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Accidental poisoning by and exposure to alcohol

0.94

0.00

1.2

1.1

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

0.86

0.00

1.0

1.1

—

Assault by drugs, medicaments and biological substances

0.00

0.0

1.0

—

Traumatic amputation of shoulder and upper arm

0.00

0.0

1.2

—

Granulosa cell carcinoma of ovary

0.00

0.0

1.3

—

Exposure to high and low air pressure and changes in air pressure

0.00

0.0

1.2

—

Malignant neoplasm of oropharyng

0.00

0.0

1.0

—

Intentional self-harm by drowning and submersion

0.00

0.0

1.4

—

Pedestrian injured in collision with car, pick-up truck or van

0.91

0.00

1.0

1.1

—

Defect, injury or illness of face

0.00

0.0

1.4

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

0.0

1.0

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.0

1.3

—

Carcinoma in situ of other and unspecified genital organs

0.92

0.00

1.0

1.1

—

Ependymoma

0.00

0.0

1.4

—

Squamous cell neoplasms and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

0.00

0.0

1.0

—

Benign lipomatous neoplasm of intrathoracic organs

0.00

0.0

1.0

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.98

0.00

1.0

1.1

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.95

0.00

1.0

1.1

—

Other porphyria

0.00

0.0

1.0

—

Allergic purpura

0.92

0.00

1.0

1.1

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.0

—

Malignant neoplasm of cervix uteri

1.00

0.00

1.2

1.1

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.0

—

Transepidermal elimination disorders

0.00

0.0

1.0

—

Paranoid personality disorder

1.00

0.00

1.0

1.1

—

Injury of muscle and tendon at forearm level

1.00

0.00

1.0

1.1

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.0

1.4

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

0.0

1.0

—

Malignant neoplasm of palate

0.00

0.0

1.0

—

Carcinoma in situ of larynx

0.00

0.0

1.2

—

Benign neoplasm: Urethra

0.00

0.0

1.1

—

Melanoma in situ of scalp and neck

0.00

0.0

1.2

—

Carcinoma in situ of lip, excluding all cancers

0.00

0.0

1.0

—

Acquired atrophy of ovary and fallopian tube

0.00

0.0

1.0

—

Carcinoma in situ of other and unspecified genital organs

0.92

0.00

1.0

1.2

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.0

—

Cicatricial pemphigoid

0.00

0.0

1.0

—

Cyst of spleen

0.00

0.0

1.0

—

Severe bullous disorders, KELA reimbursement

0.00

0.0

1.0

—

Other helminthiases

0.00

0.0

1.0

—

Cystic fibrosis with intestinal manifestations

0.00

0.0

1.0

—

Postpolio syndrome

0.00

0.0

1.0

—

Eccrine sweat disorders

0.00

0.0

1.3

—

Plasmodium falciparum malaria

0.00

0.0

1.0

—

Solar urticaria

0.00

0.0

1.0

—

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

Osteochondrodysplasia with defects of growth of tubular bones and spine

0.00

0.0

1.3

—

Lichen striatus

0.00

0.0

1.2

—

Defect, injury or illness of lumbar spine

0.00

0.0

1.3

—

Rheumatic heart disease, other

0.00

0.0

1.3

—

Diphtheria

0.00

0.0

1.1

—

Benign neoplasm: Renal pelvis

0.00

0.0

1.0

—

Other parasitologically confirmed or unspecified malaria

0.00

0.0

1.0

—

Corrosions classified according to extent of body surface involved

0.00

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

590

1.00

0.00

1.0

1.1

—

88.49

—

Other disorders following mastoidectomy

0.00

0.0

1.1

—

Operations 1 for CAVS

0.00

0.0

1.0

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.0

—

Malignant otitis externa

0.00

0.0

1.0

—

Other rupture of muscle

0.00

0.0

1.1

—

Polyp of middle ear

0.00

0.0

1.0

—

Hypotony of eye

0.00

0.0

1.0

—

Phantom limb syndrome

0.00

0.0

1.0

—

Vascular dementia (sudden onset)

0.00

0.0

1.0

—

Cystic fibrosis

0.00

0.0

1.0

—

Other and unspecified disorders of globe

0.00

0.0

1.0

—

Rheumatic fever incl heart disease

0.99

0.00

1.0

1.1

—

Maxillary retrognathism

0.99

0.00

1.0

1.1

—

Disorders of vagus nerve

0.00

0.0

1.0

—

Folliculitis decalvans

0.00

0.0

1.0

—

Other acantholytic disorders

0.00

0.0

1.0

—

Unspecified hairloss

0.00

0.0

1.0

—

Disorders of tyrosine metabolism

0.00

0.0

1.0

—

Disorders of purine and pyrimidine metabolism, other/unspecified

0.00

0.0

1.4

—

Granulomatous disorders of skin and subcutaneous tissue

0.95

0.00

1.0

1.1

—

Ascorbic acid deficiency

0.00

0.0

1.0

—

Enteropathogenic Escherichia coli infection

0.00

0.0

1.3

—

Disorder of bilirubin metabolism, other/unspecified

0.00

0.0

1.0

—

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.3

—

Diffuse (eosinophilic) fasciitis

0.00

0.0

1.0

—

Sunburn

0.00

0.0

1.4

—

Lipoprotein deficiency

0.00

0.0

1.2

—

Perioral dermatitis, drug-induced

0.00

0.0

1.4

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.02

0.00

1.2

1.1

—

Iodine-deficiency-related goitre

0.00

0.0

1.0

—

Juvenile dermatomyositis

0.00

0.0

1.3

—

Other hypertrophic osteoarthropathy

0.00

0.0

1.0

—

Other fibroblastic disorders

0.00

0.0

1.0

—

Knuckle pads

0.00

0.0

1.0

—

Chronic postrheumatic arthropathy [Jaccoud]

0.00

0.0

1.0

—

Thyroiditis, unspecified

0.93

0.00

1.2

1.1

—

Fluid overload

0.00

0.0

1.0

—

Other recurrent vertebral subluxation

0.00

0.0

1.3

—

Drug-induced acute pancreatitis

0.00

0.0

1.0

—

Obstetric embolism

0.00

0.0

1.0

—

Drug-induced gout

0.00

0.0

1.0

—

Hydatidiform mole

0.89

0.00

1.0

1.1

—

Adrenomedullary hyperfunction

0.00

0.0

1.0

—

Sickle-cell disorders

0.00

0.0

1.3

—

IgA nephropathy (IgA glomerulonephritis)

1.01

0.00

1.3

1.1

—

Interstitial emphysema and related conditions originating in the perinatal period

0.00

0.0

1.0

—

Disorders of amino-acid transport

0.00

0.0

1.0

—

Convulsions of newborn

0.00

0.0

1.0

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.96

0.00

1.0

1.1

—

Secondary sideroblastic anaemia

0.00

0.0

1.0

—

Abnormalities of ear ossicles

0.00

0.0

1.0

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.0

1.0

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.0

1.0

—

Asphyxiation

0.00

0.0

1.3

—

Congenital lactase deficiency

0.00

0.0

1.3

—

Phantom limb syndrome with pain

0.00

0.0

1.0

—

Qualitative platelet defects

0.00

0.0

1.1

—

Other disturbances of cerebral status of newborn

0.00

0.0

1.4

—

Respiratory distress of newborn

0.99

0.00

1.2

1.0

—

Chromomycosis and phaeomycotic abscess

0.00

0.0

1.0

—

Use of trihexyphenidyl

0.00

0.0

1.0

—

Hypergammalglobulinemia, unspecified

0.00

0.0

1.0

—

Carcinoma in situ of other and unspecified sites

0.90

0.00

1.0

—

Spina bifida

0.00

0.0

1.4

—

Duodenal ulcer - Chronic without haemorrhage or perforation, drug-induced

0.00

0.0

1.0

—

Congenital malformations of breast

0.91

0.00

1.0

1.1

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.0

—

Congenital glaucoma

0.00

0.0

1.0

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.0

—

Noonan syndrome

0.00

0.0

1.3

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.3

—

Guttate psoriasis

1.00

-0.00

1.0

1.1

—

0.00

-0.00

0.0

1.0

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS